<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Sci Rep</journal-id><journal-id journal-id-type="iso-abbrev">Sci Rep</journal-id><journal-title-group><journal-title>Scientific Reports</journal-title></journal-title-group><issn pub-type="epub">2045-2322</issn><publisher><publisher-name>Nature Publishing Group UK</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40394023</article-id><article-id pub-id-type="pmc">PMC12092607</article-id>
<article-id pub-id-type="publisher-id">773</article-id><article-id pub-id-type="doi">10.1038/s41598-025-00773-1</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Chemical composition of Egyptian propolis and studying its antimicrobial activity and synergistic action with honey against some multidrug-resistant uropathogens</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Helmy</surname><given-names>Asmaa K.</given-names></name><address><email>AsmaaHelmy.5622@azhar.edu.eg</email><email>asmaakmal6@gmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Sidkey</surname><given-names>Nagwa M.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Abdel-Aziz</surname><given-names>Marwa M.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>El-Hela</surname><given-names>Atef A.</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05fnp1145</institution-id><institution-id institution-id-type="GRID">grid.411303.4</institution-id><institution-id institution-id-type="ISNI">0000 0001 2155 6022</institution-id><institution>Botany and Microbiology Department, Faculty of Science for Girls, </institution><institution>Al-Azhar University, </institution></institution-wrap>Cairo, Egypt </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05fnp1145</institution-id><institution-id institution-id-type="GRID">grid.411303.4</institution-id><institution-id institution-id-type="ISNI">0000 0001 2155 6022</institution-id><institution>The Regional Centre for Mycology and Biotechnology, </institution><institution>Al-Azhar University, </institution></institution-wrap>Cairo, Egypt </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05fnp1145</institution-id><institution-id institution-id-type="GRID">grid.411303.4</institution-id><institution-id institution-id-type="ISNI">0000 0001 2155 6022</institution-id><institution>Pharmacognosy and Medicinal Plants Department, Faculty of Pharmacy, </institution><institution>Al-Azhar University, </institution></institution-wrap>Cairo, Egypt </aff></contrib-group><pub-date pub-type="epub"><day>20</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>20</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>15</volume><elocation-id>17484</elocation-id><history><date date-type="received"><day>18</day><month>2</month><year>2025</year></date><date date-type="accepted"><day>30</day><month>4</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">Urinary tract infection (UTI) is one of the most common infections worldwide, increasing the incidence of antibiotic resistance and creating demand for alternative antimicrobial agents. Propolis, a natural antimicrobial agent, has been used in ancient folk medicine. This study evaluates the effectiveness of ethanolic extract of propolis (EEP) alone and in combination with honey against multidrug-resistant (MDR) uropathogens and also investigates the chemical composition of Egyptian propolis, which may be a potential therapeutic approach against MDR uropathogens. EEP was prepared, followed by column chromatographic fractionation using four different solvent systems. The ethyl acetate fraction was further fractionated through vacuum liquid chromatography (VLC). The antimicrobial activity of the EEP, propolis fractions, honey, and EEP-Honey mixture was studied, and the fraction with the best antimicrobial activity was analyzed by GC-MS and HPLC. The results indicated that EEP showed antimicrobial activity against the five MDR uropathogens with varying potential, while honey showed no activity against these pathogens. In comparison, the EEP-Honey mixture exhibited good antimicrobial synergy, with the MIC value decreasing by approximately 4&#x02013;8 folds. In propolis fractionation, ethyl acetate was the best solvent for extracting antimicrobial substances from EEP, and fraction 5 (F5) was the most active fraction, with inhibition zone diameters of 30.33, 29.00, 21.58, 25.33, and 27.67&#x000a0;mm against MDR <italic>P. aeruginosa</italic>, <italic>E. coli</italic>, <italic>K. pneumoniae</italic>, <italic>S. saprophyticus</italic>, and <italic>C. albicans</italic>, respectively. GC-MS analysis of the F5 fraction revealed the presence of phenolics, flavonoids, terpenoids, acids, and alkaloids. In addition, HPLC polyphenol analysis identified 14 phenolic acids and flavonoid compounds with concentrations ranging from 117.36 to 5657.66&#x000a0;&#x000b5;g/g. Overall, the current findings highlighted the promising antimicrobial synergy of the EEP-Honey mixture against MDR urinary pathogens. The phytochemical analysis of propolis also identified potential bioactive compounds responsible for its biological and pharmaceutical properties.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Uropathogens</kwd><kwd>Propolis</kwd><kwd>Antimicrobial activity</kwd><kwd>EEP</kwd><kwd>Ethanolic extract of propolis</kwd><kwd>Active fraction</kwd><kwd>GC-MS</kwd><kwd>HPLC</kwd></kwd-group><kwd-group kwd-group-type="npg-subject"><title>Subject terms</title><kwd>Antimicrobials</kwd><kwd>Microbiology techniques</kwd><kwd>Chromatography</kwd></kwd-group><funding-group><award-group><funding-source><institution>Al-Azhar University</institution></funding-source></award-group><open-access><p>Open access funding provided by The Science, Technology &#x00026; Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB).</p></open-access></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer Nature Limited 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par16">Urinary tract infections (UTIs) are among the most well-known community and hospital-associated microbial infections, affecting more than 150&#x000a0;million people annually worldwide<sup><xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR2">2</xref></sup>. They are among the most frequent complications in critical care patients<sup><xref ref-type="bibr" rid="CR2">2</xref>,<xref ref-type="bibr" rid="CR3">3</xref></sup>. Generally, antibiotics are prescribed as empiric therapy even as the result of urine culture, and this approach has probably contributed to the increase in antibiotic resistance worldwide<sup><xref ref-type="bibr" rid="CR4">4</xref></sup>. Thus, the improper use of antibiotics may delay effective treatment and participate in the emergence of multidrug-resistant (MDR) microbes<sup><xref ref-type="bibr" rid="CR5">5</xref>,<xref ref-type="bibr" rid="CR6">6</xref></sup>. The World Health Organization (WHO) and other researchers have emphasized the urgent need for novel antimicrobial approaches to combat infectious diseases<sup><xref ref-type="bibr" rid="CR7">7</xref>&#x02013;<xref ref-type="bibr" rid="CR9">9</xref></sup>.</p><p id="Par17">Propolis, or bee glue, is a naturally occurring sticky material that belongs to the family of bee products<sup><xref ref-type="bibr" rid="CR9">9</xref>,<xref ref-type="bibr" rid="CR10">10</xref></sup>. The word &#x0201c;propolis&#x0201d; originates from two ancient Greek words: <italic>pro</italic>- means &#x0201c;in front of&#x0201d; or &#x0201c;at the entrance,&#x0201d; and <italic>polis</italic> means &#x0201c;city&#x0201d; or &#x0201c;community,&#x0201d; collectively referring to a substance used to defend the hive<sup><xref ref-type="bibr" rid="CR10">10</xref>,<xref ref-type="bibr" rid="CR11">11</xref></sup>. Propolis is collected by worker bees from the resinous secretions of a variety of plant species, such as pine, poplar, alder, conifer, beech, and birch, and then mixed with enzymatic and salivary bee secretions to form bee glue<sup><xref ref-type="bibr" rid="CR12">12</xref>,<xref ref-type="bibr" rid="CR13">13</xref></sup>.</p><p id="Par18">Propolis has been used in folk medicine since ~&#x02009;300 BC and is reported to have several biological activities, including antibacterial, fungicidal<sup><xref ref-type="bibr" rid="CR9">9</xref>,<xref ref-type="bibr" rid="CR14">14</xref></sup>, antiviral, immunomodulator<sup><xref ref-type="bibr" rid="CR15">15</xref>,<xref ref-type="bibr" rid="CR16">16</xref></sup>, anti-inflammatory<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>, antioxidant<sup><xref ref-type="bibr" rid="CR17">17</xref>,<xref ref-type="bibr" rid="CR18">18</xref></sup>, and antitumor<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>. Furthermore, a previous study has demonstrated the good effect of propolis in increasing the growth rate of some types of probiotic bacteria<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>.</p><p id="Par19">Indeed, the raw propolis consists of 45 to 55% plant resin, 25 to 35% beeswax, 5 to 10% aromatic and essential oil, 5% pollen, and 5% other natural constituents<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>. Propolis also contains various sorts of secondary plant metabolites, such as phenolic acids, tannins, terpenoids, alkaloids, and flavonoids, which are responsible for several bioactivities and differ in concentrations depending on the season, plant sources, and geographical origins<sup><xref ref-type="bibr" rid="CR9">9</xref>,<xref ref-type="bibr" rid="CR22">22</xref>,<xref ref-type="bibr" rid="CR23">23</xref></sup>. It has many targeted sites with strong activity, attributed to its phenolic constituents, so it can potentially increase the effectiveness of other antimicrobial agents and act synergistically<sup><xref ref-type="bibr" rid="CR24">24</xref></sup>. The current study aimed to investigate the antimicrobial activity of the crude ethanolic extract of propolis (EEP), its synergistic effects when combined with honey, and the chemical composition of propolis responsible for its antimicrobial properties.</p></sec><sec id="Sec2"><title>Materials and methods</title><sec id="Sec3"><title>Preparation of propolis extract, honey, and their mixture</title><p id="Par20">A raw Egyptian propolis sample was obtained from the Abd El-Raheam apiary located in Marsa Matrouh, Egypt, and stored in a sterile glass container in the refrigerator, away from sunlight, until extraction. It was extracted with 70% ethanol (1:10, w/v), according to Helmy et al.<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>. The sample was incubated under agitation for seven days at 37&#x000a0;&#x000b0;C, protected from light, followed by centrifugation for 10&#x000a0;min. The supernatant was dried at 40&#x000a0;&#x000b0;C until ethanol evaporation occurred to obtain the pure propolis extract in powder form. This powder was weighed and dissolved in 1% DMSO (Sigma-Aldrich) to obtain EEP at a concentration of 100&#x000a0;mg/ml.</p><p id="Par21">An Egyptian Citrus honey sample was obtained from the Egyptian Ministry of Agriculture, Giza, Egypt, and stored in a sterile glass container at room temperature. It was prepared in a 50% (v/v) concentration by adding an equal volume of honey to an equal volume of sterile distilled water in a sterile test tube. The honey solution was mixed by stirring with a vortex.</p><p id="Par22">A mixture of EEP and honey (EEP-Honey) was prepared (1:1 v/v) to get a mixture of the final concentration (100&#x000a0;mg EEP/ 50% honey) to study the antimicrobial synergism between propolis and honey.</p></sec><sec id="Sec4"><title>Tested uropathogens</title><p id="Par23">Five MDR uropathogens were used in the current study, including one yeast isolate: fluconazole-resistant <italic>Candida albicans</italic>, one strain of Gram-positive bacteria: oxacillin and mecillinam-resistant Coagulase Negative (CON) <italic>Staphylococcus saprophyticus</italic>, and 3 Gram-negative MDR bacteria included extended-spectrum beta-lactamases (ESBL) <italic>Klebsiella pneumoniae</italic>, as well as MDR <italic>E. coli</italic> and <italic>Pseudomonas aeruginosa</italic>, which resisted to ceftazidime, cefepime, aztreonam, ciprofloxacin, piperacillin, imipenem, and gentamicin.</p><p id="Par24">All urinary pathogens were provided by the Clinical Microbiology Laboratory of Cleopatra Hospital, Cairo, Egypt, from urine and catheter specimens whose patients were suffering from UTIs. These pathogens were identified according to the VITEK 2 system. VITEK 2 (bioM&#x000e9;rieux) is an automated, highly accurate microbial identification system based on phenotypic identification methods. This system accommodates colorimetric reagent cards that are automatically incubated and interpreted. Four reagent cards are used for the identification of different microorganisms: (GN) for Gram&#x02013;negative bacteria; (GP) for Gram&#x02013;positive cocci and non-spore-forming bacilli; (BCL) for Gram&#x02013;positive spore-forming bacilli; and (YST) for yeasts and yeast-like microorganisms. Each reagent card contains 64 wells, each containing an individual test substrate for measuring different metabolic activities<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>.</p></sec><sec id="Sec5"><title>Antimicrobial activity of EEP, Propolis fractions, and honey</title><sec id="Sec6"><title>Agar well diffusion method</title><p id="Par25">Antimicrobial activities of EEP, propolis fractions, honey, and DMSO were determined by the agar well diffusion method on Mueller-Hinton agar (Oxoid, UK) for bacteria and on 2% glucose-supplemented Mueller-Hinton agar for <italic>Candida</italic> spp<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>. This test was carried out in the Biotechnology Lab, Faculty of Science, Al-Azhar University for Girls, Cairo, Egypt, according to the National Committee for Clinical Laboratory Standards<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>.</p><p id="Par26">Each uropathogen was freshly prepared and cultured on nutrient agar at 35&#x02013;37&#x000a0;&#x000b0;C overnight. An inoculum of 1.5&#x02009;&#x000d7;&#x02009;10<sup>8</sup> CFU/ml (equivalent to 0.5 McFarland) was prepared in sterile saline (0.85%) and swabbed over the surface of the prepared Mueller-Hinton agar plate. EEP and propolis fractions were prepared at a 100&#x000a0;mg/ml concentration. Wells were prepared in each plate using a sterile cork borer with a diameter of 8&#x000a0;mm and a volume of 100&#x000a0;&#x000b5;l of EEP, propolis fractions, honey (50% v/v), and DMSO (negative control) were dropped in each well. Also, cefotaxime (CTX 30), ciprofloxacin (CIP 5), and fluconazole 25&#x000a0;&#x000b5;g discs were used as positive controls, the zone of inhibition was measured, and results were interpreted according to the Clinical and Laboratory Standards Institute<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>. The plates were placed in the refrigerator for 1&#x02013;2&#x000a0;h to allow the extracts to diffuse into the medium<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>. Then, the plates were incubated at 35&#x02013;37&#x000a0;&#x000b0;C for 18&#x02013;24&#x000a0;h, and the inhibition zone diameters (IZDs) were measured in mm. The experiment was performed in duplicate, and the mean&#x02009;&#x000b1;&#x02009;standard error (SE) of the results was calculated.</p></sec><sec id="Sec7"><title>Minimum inhibitory concentration (MIC) determination</title><p id="Par27">The MIC value of EEP was evaluated using the broth microdilution method in the Regional Center for Mycology and Biotechnology, Cairo, Egypt, according to Helmy et al.<sup><xref ref-type="bibr" rid="CR9">9</xref></sup> study. At 96 well microtiter plates (BioTek, Winooski, VT, USA), an inoculum of each uropathogen suspension (1.5&#x02009;&#x000d7;&#x02009;10<sup>8</sup> CFU/ml) was incubated with broth containing different concentrations of EEP (0.12&#x02013;125&#x000a0;mg/ml) for 24&#x000a0;h at 37&#x000a0;&#x000b0;C. The MIC value was estimated by visual and spectroscopic methods by absorbance measurement at 620&#x000a0;nm. Control tubes without uropathogen (negative controls) and without EEP (positive controls) were used. The experiment was performed in duplicate, and the MIC&#x02009;&#x000b1;&#x02009;standard error (SE) of the results was calculated.</p></sec></sec><sec id="Sec8"><title>Antimicrobial synergism of the EEP-Honey mixture</title><p id="Par28">Antimicrobial synergy testing of the EEP-Honey mixture against MDR uropathogens was performed using the agar well diffusion method and MIC determination, as previously described in the above sections. However, in determining the MIC, different concentrations of the EEP-Honey mixture were prepared (1:1 v/v) below the MIC value of EEP, and these mixtures were screened against MDR uropathogens as described above. The synergism was defined when the MIC value of the EEP-Honey mixture reduced the MIC value of EEP alone<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>, as all urinary pathogens were resistant to honey.</p></sec><sec id="Sec9"><title>Phytochemical analysis of propolis extract</title><p id="Par29">Phytochemical analysis of propolis was performed at the Faculty of Pharmacy at Al-Azhar University for boys in Cairo, Egypt, according to Afsar et al.<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>, with some modifications, Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>. About 200&#x000a0;g of propolis was extracted with 70% ethanol to obtain EEP. The dried EEP was re-suspended in 300&#x000a0;ml of water and subjected to successive liquid-liquid extraction using petroleum ether, chloroform, ethyl acetate, and n-butanol solvent systems, and their antimicrobial activities were studied. The ethyl acetate fraction (the highest in the antimicrobial activity) was subjected to further fractionation through vacuum liquid chromatography (VLC) on silica gel column and eluted with dichloromethane (DCM), dichloromethane (DCM): ethyl acetate (80:20, 60:40, 40:60, and 20:80 v/v), ethyl acetate (EtAc): methanol (MeOH) (1:1), and methanol (MeOH) to afford seven fractions in powder form, named (F1-F7) Fig.&#x000a0;1. The antimicrobial activity of the seven purified fractions was studied against MDR uropathogens, and the fraction with the highest antimicrobial activity was analyzed by gas-chromatography mass-spectrometry (GC-MS) and high-performance liquid chromatography (HPLC).</p><p id="Par30">
<fig id="Fig1"><label>Fig. 1</label><caption><p>Propolis fractionation and purification of the most active antimicrobial substance. VLC: vacuum liquid chromatography, DCM: dichloromethane, EtAc: ethyl acetate, MeOH: methanol, GC-MS: gas chromatography-mass spectrometry, HPLC: high-performance liquid chromatography, +++ ve: strong positive activity, F1- F7: fraction 1- fraction 7.</p></caption><graphic xlink:href="41598_2025_773_Fig1_HTML" id="d33e505"/></fig>
</p></sec><sec id="Sec10"><title>Characterization of the most active propolis fraction</title><p id="Par33">The most active fraction (F5) with the highest antimicrobial activity was analyzed by GC-MS and HPLC polyphenol analysis to predict the empirical chemical structure, molecular formula, and nomenclature of the most active compounds.</p><sec id="Sec11"><title>GC-MS analysis of propolis active fraction (F5)</title><p id="Par34">The GC-MS system (Agilent Technologies) was equipped with a gas chromatograph (7890B) and mass spectrometer detector (5977&#x000a0;A) at Central Laboratories Network, National Research Centre; Cairo, Egypt. The active propolis fraction (F5) derivatizations were carried out using trimethylsilyl (TMS) derivatization and based on the optimized protocol described by Villas-B&#x000f4;as et al.<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>. In summary, dried samples were re-suspended in 20 &#x000b5;L of pyridine and 100 &#x000b5;L of <italic>N</italic>-Methyl-<italic>N</italic>-(trimethylsilyl) trifluoroacetamide (MSTFA) and incubated in a dry block heater at 70&#x000a0;&#x000b0;C for 60&#x000a0;min. The GC was equipped with an HP-5MS column (30&#x000a0;m x 0.25&#x000a0;mm internal diameter and 0.25 <italic>&#x000b5;</italic>m film thickness). Analyses were carried out using helium as the carrier gas at a flow rate of 1.0&#x000a0;ml/min at a splitless injection volume of 2&#x000a0;&#x000b5;l and the following temperature program: 50&#x000a0;&#x000b0;C for 10&#x000a0;min; rising at 8&#x000a0;&#x000b0;C/min to 300&#x000a0;&#x000b0;C and held for 10&#x000a0;min. The injector and detector were held at 280&#x000a0;&#x000b0;C and 220&#x000a0;&#x000b0;C, respectively. Mass spectra were obtained by electron ionization (EI) at 70&#x000a0;eV using a spectral range of 50&#x02013;550&#x000a0;m/z and a solvent delay of 10&#x000a0;min. The mass temperature was 230&#x000a0;&#x000b0;C and Quad 150&#x000a0;&#x000b0;C. Identification of different constituents was determined by comparing the spectrum fragmentation pattern with those stored in Wiley and NIST Mass Spectral Library data.</p></sec><sec id="Sec12"><title>HPLC analysis of propolis active fraction (F5)</title><p id="Par35">HPLC polyphenol analysis of the most active fraction was carried out using an Agilent 1260 series. The separation was carried out using a Kromasil C18 column (4.6&#x000a0;mm x 250&#x000a0;mm i.d., 5&#x000a0;&#x003bc;m). The mobile phase consisted of water (A) and 0.05% trifluoroacetic acid in acetonitrile (B) at a flow rate of 1&#x000a0;ml/min. The mobile phase was programmed consecutively in a linear gradient as follows: 0&#x000a0;min (82% A); 0&#x02013;5&#x000a0;min (80% A); 5&#x02013;8&#x000a0;min (60% A); 8&#x02013;12&#x000a0;min (60% A); 12&#x02013;15&#x000a0;min (85% A) and 15&#x02013;16&#x000a0;min (82% A). The injection volume was 10&#x000a0;&#x000b5;l for each of the sample solutions (15&#x000a0;mg/ml). The column temperature was maintained at 35&#x000a0;&#x000b0;C. Polyphenol compounds were assayed by external standard calibration at 280&#x000a0;nm. HPLC analysis was carried out in the Central Laboratories Network, National Research Centre, Cairo, Egypt<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>.</p></sec></sec><sec id="Sec13"><title>Data analysis</title><p id="Par36">Data were presented as mean, and standard error (SE) was determined. Data were normally distributed, and statistical analysis was performed using ANOVA one-way LSD tests. The software package CoStat for Windows version 6.45 was used for data analysis. A <italic>P value</italic> of &#x0003c;&#x02009;0.05 was considered statistically significant for all analyses.</p></sec></sec><sec id="Sec14"><title>Results</title><sec id="Sec15"><title>Antimicrobial activity of EEP and its synergistic action with honey</title><p id="Par37">In this study, the antimicrobial activity of EEP and its synergistic action with honey was determined by recording their IZDs and MIC values on MDR uropathogens. DMSO (negative control) was considered an inert solvent and didn&#x02019;t report any inhibitory action on all MDR uropathogens. Also, cefotaxime (CTX 30), ciprofloxacin (CIP 5), and fluconazole 25-&#x000b5;g discs were used as positive controls and didn&#x02019;t report inhibitory action on all MDR uropathogens since IZD less than 12&#x000a0;mm &#x02014;for most antibiotics&#x02014; was considered as resistant according to the Clinical and Laboratory Standards Institute breakpoints. Honey has not recorded any antimicrobial action, while EEP showed an inhibitory effect with variable action on all MDR uropathogens. Indeed, EEP showed higher activity against <italic>C. albicans</italic> and <italic>S. saprophyticus</italic> with IZDs of 21.67 and 21.33&#x000a0;mm and MIC values of 3.51 and 3.90&#x000a0;mg/ml, respectively, followed by <italic>P. aeruginosa</italic>,<italic> K. pneumonia</italic>, and <italic>E.</italic> coli with IZDs of 15.00, 13.83, and 12.58&#x000a0;mm, respectively, and MIC value ranged between 14.66 and 31.25&#x000a0;mg/ml; as shown in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>.</p><p id="Par38">When propolis was mixed with honey, the mixture (EEP-Honey) showed a significant increase in its IZD in the range of 16.58&#x02013;26.00&#x000a0;mm and a decrease in its MIC values compared to EEP alone against MDR uropathogens, as a good synergistic action was recorded. The results of the synergistic effect in Table&#x000a0;1 indicated that MDR Gram-negative uropathogens showed a decrease in their MIC value from 14.66 to 31.25&#x000a0;mg/ml in EEP to 1.95&#x02013;7.81&#x000a0;mg/ml in the EEP-Honey mixture. Moreover, MDR <italic>S. saprophyticus</italic> and fluconazole-resistant <italic>C. albicans</italic> showed a decrease in the MIC values from 3.90 to 3.51&#x000a0;mg/ml in EEP to 0.98 and 0.95&#x000a0;mg/ml in the EEP-Honey mixture, respectively, when treated with (EEP-Honey) mixture.</p><p id="Par39">The <italic>p-values</italic> &#x0200b;&#x0200b;indicated that the EEP-Honey treatment option had a significantly greater antimicrobial effect than EEP alone across all tested pathogens. Thus, the statistical analysis suggests that honey enhances the antimicrobial properties of EEP, making EEP&#x02009;+&#x02009;Honey mixture a more effective treatment option.</p><p id="Par41">
<table-wrap id="Tab1"><label>Table 1</label><caption><p>Antimicrobial activity of positive and negative controls, EEP, honey, and EEP-Honey mixture against MDR uropathogens.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">pathogen</th><th align="left" colspan="7">Mean IZD (mm)&#x02009;&#x000b1;&#x02009;SE</th><th align="left" colspan="2">MIC (mg/ml)</th></tr><tr><th align="left">CTX 30</th><th align="left">CIP 5</th><th align="left">Flu 25</th><th align="left">DMSO</th><th align="left">EEP<break/>(100&#x000a0;mg/ml)</th><th align="left">Honey<break/>(50%)</th><th align="left">EEP&#x02009;+&#x02009;Honey</th><th align="left">EEP</th><th align="left">EEP&#x02009;+&#x02009;Honey</th></tr></thead><tbody><tr><td align="left">
<bold><italic>E. coli</italic></bold>
</td><td align="left">0.00&#x02009;&#x000b1;&#x02009;0.00</td><td align="left">8.00&#x02009;&#x000b1;&#x02009;0.58</td><td align="left">NA</td><td char="&#x000b1;" align="char">0.00&#x02009;&#x000b1;&#x02009;0.00</td><td align="left">12.85<sup>c, B&#x000a0;</sup>&#x000b1; 0.67</td><td char="&#x000b1;" align="char">0.00&#x02009;&#x000b1;&#x02009;0.00</td><td align="left">16.58<sup>c, A&#x000a0;</sup>&#x000b1; 0.17</td><td align="left">31.25<sup>a, A&#x000a0;</sup>&#x000b1; 1.52</td><td align="left">7.81<sup>c, B&#x000a0;</sup>&#x000b1; 0.64</td></tr><tr><td align="left">
<bold><italic>K. pneumoniae</italic></bold>
</td><td align="left">0.00&#x02009;&#x000b1;&#x02009;0.00</td><td align="left">9.33&#x02009;&#x000b1;&#x02009;0.67</td><td align="left">NA</td><td char="&#x000b1;" align="char">0.00&#x02009;&#x000b1;&#x02009;0.00</td><td align="left">13.83<sup>bc, B&#x000a0;</sup>&#x000b1; 0.44</td><td char="&#x000b1;" align="char">0.00&#x02009;&#x000b1;&#x02009;0.00</td><td align="left">20.67<sup>b, A&#x000a0;</sup>&#x000b1; 0.58</td><td align="left">15.63<sup>b, A&#x000a0;</sup>&#x000b1; 0.87</td><td align="left">3.9<sup>c, B&#x000a0;</sup>&#x000b1; 0.51</td></tr><tr><td align="left">
<bold><italic>P. aeruginosa</italic></bold>
</td><td align="left">0.00&#x02009;&#x000b1;&#x02009;0.00</td><td align="left">0.00&#x02009;&#x000b1;&#x02009;0.00</td><td align="left">NA</td><td char="&#x000b1;" align="char">0.00&#x02009;&#x000b1;&#x02009;0.00</td><td align="left">15.00<sup>b, B&#x000a0;</sup>&#x000b1; 0.58</td><td char="&#x000b1;" align="char">0.00&#x02009;&#x000b1;&#x02009;0.00</td><td align="left">21.33<sup>b, A&#x000a0;</sup>&#x000b1; 0.33</td><td align="left">14.66<sup>b, A&#x000a0;</sup>&#x000b1; 0.45</td><td align="left">1.95<sup>bc, B&#x000a0;</sup>&#x000b1; 0.19</td></tr><tr><td align="left">
<bold><italic>S. saprophyticus</italic></bold>
</td><td align="left">7.00&#x02009;&#x000b1;&#x02009;0.00</td><td align="left">0.00&#x02009;&#x000b1;&#x02009;0.00</td><td align="left">NA</td><td char="&#x000b1;" align="char">0.00&#x02009;&#x000b1;&#x02009;0.00</td><td align="left">21.33<sup>a, B&#x000a0;</sup>&#x000b1; 0.58</td><td char="&#x000b1;" align="char">0.00&#x02009;&#x000b1;&#x02009;0.00</td><td align="left">25.67<sup>a, A&#x000a0;</sup>&#x000b1; 0.33</td><td align="left">3.90<sup>c, A&#x000a0;</sup>&#x000b1; 0.37</td><td align="left">0.98<sup>b, B&#x000a0;</sup>&#x000b1; 0.21</td></tr><tr><td align="left">
<bold><italic>C. albicans</italic></bold>
</td><td align="left">NA</td><td align="left">NA</td><td align="left">0.00&#x02009;&#x000b1;&#x02009;0.00</td><td char="&#x000b1;" align="char">0.00&#x02009;&#x000b1;&#x02009;0.00</td><td align="left">21.67<sup>a, B&#x000a0;</sup>&#x000b1; 0.33</td><td char="&#x000b1;" align="char">0.00&#x02009;&#x000b1;&#x02009;0.00</td><td align="left">26.00<sup>a, A&#x000a0;</sup>&#x000b1; 0.67</td><td align="left">3.51<sup>c, A&#x000a0;</sup>&#x000b1; 0.72</td><td align="left">0.95<sup>b, B&#x000a0;</sup>&#x000b1; 0.48</td></tr></tbody></table><table-wrap-foot><p>SE&#x02009;=&#x02009;Standard error, CTX 30: Cefotaxime, CIP 5: Ciprofloxacin, Flu 25: Fluconazole, NA: Not applicable.</p><p>Different small letters indicate significant differences within the same column (<italic>p-value</italic>&#x02009;&#x0003c;&#x02009;0.05).</p><p>Different capital letters indicate significant differences (<italic>p-value</italic>&#x02009;&#x0003c;&#x02009;0.05) between columns in the same test.</p><p>A <italic>p-value</italic>&#x02009;&#x0003c;&#x02009;0.05 was set as representing statistical significance for all analyses.</p></table-wrap-foot></table-wrap>
</p></sec><sec id="Sec16"><title>Antimicrobial activity of the extracted substances from EEP using different solvent systems</title><p id="Par46">The data in Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>; Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref> indicated that, among all four solvent systems (petroleum ether, chloroform, ethyl acetate, and n-butanol), ethyl acetate was the best solvent for extracting the antimicrobial substance from EEP against MDR uropathogens (<italic>p-value</italic>&#x02009;&#x0003c;&#x02009;0.05), except for <italic>K. pneumonia</italic>, followed by n-butanol, as it gave higher activity on this pathogen.</p><p id="Par48">
<table-wrap id="Tab2"><label>Table 2</label><caption><p>Effect of different solvent systems on the antimicrobial activity of EEP against MDR uropathogens.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">pathogen</th><th align="left" colspan="4">Mean diameter of inhibition zone(mm)&#x02009;&#x000b1;&#x02009;SE</th></tr><tr><th align="left">Petroleum ether</th><th align="left">Chloroform</th><th align="left">Ethyl acetate</th><th align="left"><italic>N</italic>-butanol</th></tr></thead><tbody><tr><td align="left">
<bold><italic>E. coli</italic></bold>
</td><td align="left">9.00<sup>c</sup>&#x02009;&#x000b1;&#x02009;0.67</td><td align="left">10.67<sup>b</sup>&#x02009;&#x000b1;&#x02009;0.67</td><td align="left"><bold>12.00</bold><sup><bold>a</bold></sup>&#x02009;<bold>&#x000b1;&#x02009;0.00</bold></td><td align="left">11.00<sup>ab</sup>&#x02009;&#x000b1;&#x02009;0.00</td></tr><tr><td align="left">
<bold><italic>K. pneumoniae</italic></bold>
</td><td align="left">0.00<sup>c</sup>&#x02009;&#x000b1;&#x02009;0.00</td><td align="left">10.33<sup>b</sup>&#x02009;&#x000b1;&#x02009;0.58</td><td align="left">10.88<sup>ab</sup>&#x02009;&#x000b1;&#x02009;0.33</td><td align="left"><bold>11.67</bold><sup><bold>a</bold></sup>&#x02009;<bold>&#x000b1;&#x02009;0.67</bold></td></tr><tr><td align="left">
<bold><italic>P. aeruginosa</italic></bold>
</td><td align="left">10.58<sup>b</sup>&#x02009;&#x000b1;&#x02009;0.17</td><td align="left">11.00<sup>b</sup>&#x02009;&#x000b1;&#x02009;0.17</td><td align="left"><bold>13.67</bold><sup><bold>a</bold></sup>&#x02009;<bold>&#x000b1;&#x02009;0.67</bold></td><td align="left"><bold>13.00</bold><sup><bold>a</bold></sup>&#x02009;<bold>&#x000b1;&#x02009;0.10</bold></td></tr><tr><td align="left">
<bold><italic>S. saprophyticus</italic></bold>
</td><td align="left">11.33<sup>c</sup>&#x02009;&#x000b1;&#x02009;0.33</td><td align="left">15.00<sup>b</sup>&#x02009;&#x000b1;&#x02009;0.00</td><td align="left"><bold>20.33</bold><sup><bold>a</bold></sup>&#x02009;<bold>&#x000b1;&#x02009;0.88</bold></td><td align="left"><bold>19.33</bold><sup><bold>a</bold></sup>&#x02009;<bold>&#x000b1;&#x02009;0.58</bold></td></tr><tr><td align="left">
<bold><italic>C. albicans</italic></bold>
</td><td align="left">15.33<sup>d</sup>&#x02009;&#x000b1;&#x02009;0.67</td><td align="left">18.33<sup>c</sup>&#x02009;&#x000b1;&#x02009;0.33</td><td align="left"><bold>28.00</bold><sup><bold>a</bold></sup>&#x02009;<bold>&#x000b1;&#x02009;0.58</bold></td><td align="left">24.67<sup>b</sup>&#x02009;&#x000b1;&#x02009;0.33</td></tr></tbody></table><table-wrap-foot><p>Different small letters indicate significant differences (<italic>p-value</italic>&#x02009;&#x0003c;&#x02009;0.05) between columns in the same test, representing the effect of the different solvent systems on the antimicrobial activity of EEP against each uropathogen. A <italic>p-value</italic>&#x02009;&#x0003c;&#x02009;0.05 was set as representing statistical significance for all analyses.</p></table-wrap-foot></table-wrap>
</p><p id="Par50">
<fig id="Fig2"><label>Fig. 2</label><caption><p>Effect of different solvent systems on antimicrobial activity of EEP against MDR uropathogens.</p></caption><graphic xlink:href="41598_2025_773_Fig2_HTML" id="d33e1069"/></fig>
</p></sec><sec id="Sec17"><title>Antimicrobial activity of the fractions produced from VLC of Ethyl acetate EEP fraction</title><p id="Par52">Using a VLC silica gel column, the ethyl acetate EEP fraction was separated into seven further fractions named F1, F2, F3, F4, F5, F6, and F7. Results in Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref> and Plate <xref rid="Fig3" ref-type="fig">1</xref> declared that the antimicrobial activity of the seven fractions was ordered as follows: F5&#x02009;&#x0003e;&#x02009;F6&#x02009;&#x0003e;&#x02009;F4&#x02009;&#x0003e;&#x02009;F3&#x02009;&#x0003e;&#x02009;F7&#x02009;&#x0003e;&#x02009;F2&#x02009;&#x0003e;&#x02009;F1. Fraction 5 (F5) that was eluted with dichloromethane (DCM): ethyl acetate (20:80) was the most active and gave significant antimicrobial activity among other fractions, with IZD of 30.33, 29.00, 27.67, 25.33, and 21.58&#x000a0;mm against the MDR <italic>P. aeruginosa</italic>, <italic>E. coli</italic>, <italic>C. albicans</italic>, <italic>S. saprophyticus</italic>, and <italic>K. pneumoniae</italic>, respectively. The p-values &#x0200b;&#x0200b;indicated Fraction 5 (F5) had a significantly greater antimicrobial effect than other fractions across all tested pathogens.</p><p id="Par54">
<table-wrap id="Tab3"><label>Table 3</label><caption><p>Antimicrobial activity of the fractions produced from VLC of ethyl acetate EEP fraction against MDR uropathogens.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="3">Propolis Fractions</th><th align="left" colspan="5">pathogens</th></tr><tr><th align="left">E. coli</th><th align="left">K. pneumoniae</th><th align="left"><italic>P</italic>. aeruginosa</th><th align="left">S. saprophyticus</th><th align="left">C. albicans</th></tr><tr><th align="left" colspan="5">Mean diameter of inhibition zone(mm)&#x02009;&#x000b1;&#x02009;SE</th></tr></thead><tbody><tr><td align="left">
<bold>F1</bold>
</td><td align="left">10.33<sup>f</sup>&#x02009;&#x000b1;&#x02009;0.33</td><td align="left">0.00<sup>e</sup>&#x02009;&#x000b1;&#x02009;0.00</td><td align="left">0.00<sup>e</sup>&#x02009;&#x000b1;&#x02009;0.00</td><td align="left">10.58<sup>d</sup>&#x02009;&#x000b1;&#x02009;0.17</td><td align="left">11.00<sup>e</sup>&#x02009;&#x000b1;&#x02009;0.58</td></tr><tr><td align="left">
<bold>F2</bold>
</td><td align="left">12.00<sup>e</sup>&#x02009;&#x000b1;&#x02009;0.58</td><td align="left">12.00<sup>d</sup>&#x02009;&#x000b1;&#x02009;0.00</td><td align="left">13.33<sup>d</sup>&#x02009;&#x000b1;&#x02009;0.33</td><td align="left">20.33<sup>b</sup>&#x02009;&#x000b1;&#x02009;0.67</td><td align="left">20.00<sup>c</sup>&#x02009;&#x000b1;&#x02009;0.00</td></tr><tr><td align="left">
<bold>F3</bold>
</td><td align="left">14.67<sup>cd</sup>&#x02009;&#x000b1;&#x02009;0.33</td><td align="left">13.33<sup>cd</sup>&#x02009;&#x000b1;&#x02009;0.33</td><td align="left">15.00<sup>c</sup>&#x02009;&#x000b1;&#x02009;0.00</td><td align="left">24.00<sup>a</sup>&#x02009;&#x000b1;&#x02009;0.00</td><td align="left">23.67<sup>b</sup>&#x02009;&#x000b1;&#x02009;0.67</td></tr><tr><td align="left">
<bold>F4</bold>
</td><td align="left">15.33<sup>c</sup>&#x02009;&#x000b1;&#x02009;0.67</td><td align="left">14.00<sup>c</sup>&#x02009;&#x000b1;&#x02009;0.33</td><td align="left">15.33<sup>c</sup>&#x02009;&#x000b1;&#x02009;0.33</td><td align="left">22.00<sup>b</sup>&#x02009;&#x000b1;&#x02009;0.58</td><td align="left">23.00<sup>b</sup>&#x02009;&#x000b1;&#x02009;0.00</td></tr><tr><td align="left">
<bold>F5</bold>
</td><td align="left"><bold>29.00</bold><sup><bold>a</bold></sup>&#x02009;<bold>&#x000b1;&#x02009;0.00</bold></td><td align="left"><bold>21.58</bold><sup><bold>a</bold></sup>&#x02009;<bold>&#x000b1;&#x02009;1.17</bold></td><td align="left"><bold>30.33</bold><sup><bold>a</bold></sup>&#x02009;<bold>&#x000b1;&#x02009;0.33</bold></td><td align="left"><bold>25.33</bold><sup><bold>a</bold></sup>&#x02009;<bold>&#x000b1;&#x02009;0.67</bold></td><td align="left"><bold>27.67</bold><sup><bold>a</bold></sup>&#x02009;<bold>&#x000b1;&#x02009;0.33</bold></td></tr><tr><td align="left">
<bold>F6</bold>
</td><td align="left">27.33<sup>b</sup>&#x02009;&#x000b1;&#x02009;0.33</td><td align="left">18.00<sup>b</sup>&#x02009;&#x000b1;&#x02009;0.67</td><td align="left">24.00<sup>b</sup>&#x02009;&#x000b1;&#x02009;0.00</td><td align="left">20.67<sup>b</sup>&#x02009;&#x000b1;&#x02009;0.33</td><td align="left">21.33<sup>c</sup>&#x02009;&#x000b1;&#x02009;0.58</td></tr><tr><td align="left">
<bold>F7</bold>
</td><td align="left">14.00<sup>d</sup>&#x02009;&#x000b1;&#x02009;0.00</td><td align="left">13.00<sup>cd</sup>&#x02009;&#x000b1;&#x02009;0.10</td><td align="left">15.33<sup>c</sup>&#x02009;&#x000b1;&#x02009;0.33</td><td align="left">13.58<sup>c</sup>&#x02009;&#x000b1;&#x02009;0.17</td><td align="left">14.67<sup>d</sup>&#x02009;&#x000b1;&#x02009;0.33</td></tr></tbody></table><table-wrap-foot><p>Different small letters indicate significant differences within the same column (<italic>p-value</italic>&#x02009;&#x0003c;&#x02009;0.05). A <italic>p-value</italic>&#x02009;&#x0003c;&#x02009;0.05 was set as representing statistical significance for all analyses.</p></table-wrap-foot></table-wrap>
</p><p id="Par56">
<fig id="Fig3"><label>Plate 1</label><caption><p>Plate&#x02019;s photos reveal the antimicrobial activity of the fractions produced from VLC of ethyl acetate EEP fraction on MDR (<bold>A</bold>): <italic>E. coli</italic>, (<bold>B</bold>): <italic>K. pneumonia</italic>, (<bold>C</bold>): <italic>P. aeruginosa</italic>, (<bold>D</bold>): CON <italic>S. saprophyticus</italic>, and (<bold>E</bold>): <italic>C. albicans.</italic> Numbers from 1 to 7 indicated fraction numbers.</p></caption><graphic xlink:href="41598_2025_773_Fig3_HTML" id="d33e1434"/></fig>
</p></sec><sec id="Sec18"><title>Characterization and identification of the most active Propolis fraction</title><p id="Par59">Fraction 5 (F5) was the most active fraction and gave significant antimicrobial activity among other fractions and was consequently subjected to (GC-MS) and (HPLC) polyphenol analysis.</p><sec id="Sec19"><title>GC-MS analysis</title><p id="Par60">The GC-MS analysis of the most active fraction allowed the detection of ninety compounds in different concentrations (99.1%), including phenolics, flavonoids, terpenoids, alkaloids, and organic acids, as shown in Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>; Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>. The major compounds present in the most active fraction of the propolis (F5) were identified as caffeic acid dimethyl ether (14.63%, compound 33, RT 33.925), monopalmitoylglycerol (9.79%, compound 54, RT 38.76), and 1,6-dihydroxy-8-methoxy-3-methylanthraquinone (9.12%, compound 69, RT 41.244), which contributed to the biological activity of propolis.</p><p id="Par61">
<fig id="Fig4"><label>Fig. 3</label><caption><p>GC/MS analysis of the most active fraction of propolis.</p></caption><graphic xlink:href="41598_2025_773_Fig4_HTML" id="d33e1458"/></fig>
</p><p id="Par64">
<table-wrap id="Tab4"><label>Table 4</label><caption><p>Results of GC/MS analysis of the most active fraction of propolis.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Compound No.</th><th align="left">Retention Time (RT)</th><th align="left">compound</th><th align="left">Formula</th><th align="left">Area Sum %</th></tr></thead><tbody><tr><td align="left">1</td><td char="." align="char">18.338</td><td align="left">Butoxyethanol</td><td align="left">C<sub>6</sub>H<sub>14</sub>O<sub>2</sub></td><td char="." align="char">0.16</td></tr><tr><td align="left">2</td><td char="." align="char">22.092</td><td align="left">Silanol</td><td align="left">SiH<sub>4</sub>O</td><td char="." align="char">0.24</td></tr><tr><td align="left">3</td><td char="." align="char">22.309</td><td align="left">Cyclohexanediol</td><td align="left">C<sub>6</sub>H<sub>12</sub>O<sub>2</sub></td><td char="." align="char">0.27</td></tr><tr><td align="left">4</td><td char="." align="char">22.515</td><td align="left">Trans-cyclohexanediol</td><td align="left">C<sub>6</sub>H<sub>12</sub>O<sub>2</sub></td><td char="." align="char">0.24</td></tr><tr><td align="left">5</td><td char="." align="char">23.025</td><td align="left">Benzeneacetic acid</td><td align="left">C<sub>8</sub>H<sub>8</sub>O<sub>2</sub></td><td char="." align="char">0.28</td></tr><tr><td align="left">6</td><td char="." align="char">23.391</td><td align="left">Acetin</td><td align="left">C<sub>5</sub>H<sub>10</sub>O<sub>4</sub></td><td char="." align="char">1.37</td></tr><tr><td align="left">7</td><td char="." align="char">24.713</td><td align="left">Disiloxane, 1,3-bis(1,1 dimethylethyl)</td><td align="left">C<sub>12</sub>H<sub>30</sub>OSi<sub>2</sub></td><td char="." align="char">0.38</td></tr><tr><td align="left">8</td><td char="." align="char">24.793</td><td align="left">Resorcinol</td><td align="left">C<sub>6</sub>H<sub>6</sub>O<sub>2</sub></td><td char="." align="char">0.22</td></tr><tr><td align="left">9</td><td char="." align="char">25.05</td><td align="left">Butoxyacetate</td><td align="left">C<sub>10</sub>H<sub>20</sub>O<sub>3</sub></td><td char="." align="char">0.15</td></tr><tr><td align="left">10</td><td char="." align="char">25.256</td><td align="left">2<italic>-Aminoisobutyric</italic>&#x000a0;acid</td><td align="left">H<sub>2</sub>N-C(CH<sub>3</sub>)<sub>2</sub>-COOH</td><td char="." align="char">0.18</td></tr><tr><td align="left">11</td><td char="." align="char">25.909</td><td align="left">Oxyvaleric acid</td><td align="left">CH<sub>3</sub>(CH<sub>2</sub>)<sub>3</sub>COOH</td><td char="." align="char">0.2</td></tr><tr><td align="left">12</td><td char="." align="char">26.155</td><td align="left">Kojic acid</td><td align="left">C<sub>6</sub>H<sub>6</sub>O<sub>4</sub></td><td char="." align="char">0.2</td></tr><tr><td align="left">13</td><td char="." align="char">27.013</td><td align="left">Cinnamic acid</td><td align="left">C<sub>9</sub>H<sub>8</sub>O<sub>2</sub></td><td char="." align="char">0.72</td></tr><tr><td align="left">14</td><td char="." align="char">27.076</td><td align="left">Pyrogallol</td><td align="left">C<sub>6</sub>H<sub>6</sub>O<sub>3</sub></td><td char="." align="char">0.59</td></tr><tr><td align="left">15</td><td char="." align="char">27.396</td><td align="left">Tyrosol</td><td align="left">C<sub>8</sub>H<sub>10</sub>O<sub>2</sub></td><td char="." align="char">0.32</td></tr><tr><td align="left">16</td><td char="." align="char">28.192</td><td align="left">-4-Hydroxybenzoic acid</td><td align="left">C<sub>7</sub>H<sub>6</sub>O<sub>3</sub></td><td char="." align="char">0.56</td></tr><tr><td align="left">17</td><td char="." align="char">28.472</td><td align="left">Dodecenoic acid</td><td align="left">C<sub>12</sub>H<sub>22</sub>O<sub>2</sub></td><td char="." align="char">0.28</td></tr><tr><td align="left">18</td><td char="." align="char">29.204</td><td align="left">Dimethoxybenzene</td><td align="left">C<sub>8</sub>H<sub>10</sub>O<sub>2</sub></td><td char="." align="char">0.18</td></tr><tr><td align="left">19</td><td char="." align="char">29.433</td><td align="left">10-Undecynoic acid</td><td align="left">C<sub>11</sub>H<sub>18</sub>O<sub>2</sub></td><td char="." align="char">0.15</td></tr><tr><td align="left">20</td><td char="." align="char">30.017</td><td align="left">Phloretic acid</td><td align="left">C<sub>9</sub>H<sub>10</sub>O<sub>3</sub></td><td char="." align="char">0.22</td></tr><tr><td align="left">21</td><td char="." align="char">30.074</td><td align="left">4-Methox benzoic acid</td><td align="left">C<sub>8</sub>H<sub>8</sub>O<sub>3</sub></td><td char="." align="char">0.41</td></tr><tr><td align="left">22</td><td char="." align="char">30.417</td><td align="left">Azelaic acid</td><td align="left">C<sub>9</sub>H<sub>16</sub>O<sub>4</sub></td><td char="." align="char">0.33</td></tr><tr><td align="left">23</td><td char="." align="char">30.824</td><td align="left">Protocatechoic acid</td><td align="left">C<sub>7</sub>H<sub>6</sub>O<sub>4</sub></td><td char="." align="char">0.7</td></tr><tr><td align="left">24</td><td char="." align="char">30.95</td><td align="left">p-methoxy Cinnamic acid</td><td align="left">C<sub>10</sub>H<sub>10</sub>O<sub>3</sub></td><td char="." align="char">0.19</td></tr><tr><td align="left">25</td><td char="." align="char">31.07</td><td align="left">Falcarinol</td><td align="left">C<sub>17</sub>H<sub>24</sub>O</td><td char="." align="char">0.2</td></tr><tr><td align="left">26</td><td char="." align="char">31.762</td><td align="left">2,4-Dihydroxyacetophenone</td><td align="left">C<sub>8</sub>H<sub>8</sub>O<sub>3</sub></td><td char="." align="char">0.47</td></tr><tr><td align="left">27</td><td char="." align="char">32.077</td><td align="left">Hydroxydihydrosafrole</td><td align="left">C<sub>10</sub>H<sub>12</sub>O<sub>3</sub></td><td char="." align="char">0.25</td></tr><tr><td align="left">28</td><td char="." align="char">32.386</td><td align="left">Caffeic acid</td><td align="left">C<sub>9</sub>H<sub>8</sub>O<sub>4</sub></td><td char="." align="char">0.65</td></tr><tr><td align="left">29</td><td char="." align="char">32.569</td><td align="left">Gallic acid</td><td align="left">C<sub>7</sub>H<sub>6</sub>O<sub>5</sub></td><td char="." align="char">1.16</td></tr><tr><td align="left">30</td><td char="." align="char">33.015</td><td align="left">Ninhydrin</td><td align="left">C<sub>9</sub>H<sub>6</sub>O<sub>4</sub></td><td char="." align="char">0.16</td></tr><tr><td align="left">31</td><td char="." align="char">33.324</td><td align="left">Dimethyl caffeic acid</td><td align="left">C<sub>11</sub>H<sub>12</sub>O<sub>4</sub></td><td char="." align="char">1.4</td></tr><tr><td align="left">32</td><td char="." align="char">33.404</td><td align="left">Palmitic Acid</td><td align="left">C<sub>16</sub>H<sub>32</sub>O<sub>2</sub></td><td char="." align="char">1.29</td></tr><tr><td align="left">33</td><td char="." align="char">33.925</td><td align="left">Caffeic acid dimethyl ether</td><td align="left">C<sub>11</sub>H<sub>12</sub>O<sub>5</sub></td><td char="." align="char">
<bold>14.63</bold>
</td></tr><tr><td align="left">34</td><td char="." align="char">34.16</td><td align="left">beta.-Cholestane-alpha.,7.alpha.,12.alpha.,24.alpha.,25-pentol</td><td align="left">C<sub>27</sub>H<sub>44</sub>O<sub>5</sub></td><td char="." align="char">0.37</td></tr><tr><td align="left">35</td><td char="." align="char">34.429</td><td align="left">Benzothiophene-3-carbonitrile, 4,5,6,7-tetrahydro-2-(4-tert-butylbenzylidenamino</td><td align="left">C<sub>9</sub>H<sub>10</sub>O<sub><bold><italic>2</italic></bold></sub>S</td><td char="." align="char">0.18</td></tr><tr><td align="left">36</td><td char="." align="char">34.492</td><td align="left">1,3-Bis(pentamethyldisilanyloxy)propane</td><td align="left">C<sub>17</sub>H<sub>20</sub>O<sub>6</sub>S<sub>2</sub></td><td char="." align="char">0.31</td></tr><tr><td align="left">37</td><td char="." align="char">34.989</td><td align="left">Beta- Eudesmol</td><td align="left">C<sub>15</sub>H<sub>26</sub>O</td><td char="." align="char">0.17</td></tr><tr><td align="left">38</td><td char="." align="char">35.316</td><td align="left">13-Octadecenoic acid</td><td align="left">C<sub>18</sub>H<sub>34</sub>O<sub>2</sub></td><td char="." align="char">0.23</td></tr><tr><td align="left">39</td><td char="." align="char">35.35</td><td align="left">alpha.-D-Glucopyranoside</td><td align="left">C<sub>7</sub>H<sub>14</sub>O<sub>6</sub></td><td char="." align="char">0.29</td></tr><tr><td align="left">40</td><td char="." align="char">35.573</td><td align="left">Stearic acid</td><td align="left">C<sub>17</sub>H<sub>35</sub>CO<sub>2</sub>H</td><td char="." align="char">0.37</td></tr><tr><td align="left">41</td><td char="." align="char">36.408</td><td align="left">Heneicosanoic acid</td><td align="left">C<sub>21</sub>H<sub>42</sub>O<sub>2</sub></td><td char="." align="char">1.06</td></tr><tr><td align="left">42</td><td char="." align="char">36.494</td><td align="left">5-dimethyl-6,8-dioxooctahydro-1&#x000a0;H-1,4-methanoinden-1-yl)propanoate</td><td align="left">C<sub>13</sub>H<sub>22</sub>O<sub>2</sub></td><td char="." align="char">0.42</td></tr><tr><td align="left">43</td><td char="." align="char">36.586</td><td align="left">&#x02212;&#x02009;(3a,5-dimethyl-6,8-dioxooctahydro-1&#x000a0;H-1,4-methanoinden-1-yl)propanoate</td><td align="left">C<sub>16</sub>H<sub>30</sub>O<sub>2</sub></td><td char="." align="char">0.75</td></tr><tr><td align="left">44</td><td char="." align="char">36.689</td><td align="left">Vanillic acid</td><td align="left">C<sub>8</sub>H<sub>8</sub>O<sub>4</sub></td><td char="." align="char">0.29</td></tr><tr><td align="left">45</td><td char="." align="char">36.918</td><td align="left">1-ethyl-2-benzimidazolyl (2-methoxyphenyl)</td><td align="left">C<sub>11</sub>H<sub>14</sub>O<sub>3</sub></td><td char="." align="char">0.2</td></tr><tr><td align="left">46</td><td char="." align="char">37.021</td><td align="left">9-Octadecenamide</td><td align="left">C<sub>18</sub>H<sub>35</sub>NO</td><td char="." align="char">1.14</td></tr><tr><td align="left">47</td><td char="." align="char">37.158</td><td align="left">Urocanic Acid</td><td align="left">C<sub>6</sub>H<sub>6</sub>N<sub>2</sub>O<sub>2</sub></td><td char="." align="char">2.42</td></tr><tr><td align="left">48</td><td char="." align="char">37.244</td><td align="left">Silane, diethyl(3-methylbutoxy)octadecyloxy</td><td align="left">C<sub>5</sub>H<sub>11</sub>Cl<sub><bold><italic>3</italic></bold></sub>Si</td><td char="." align="char">1.31</td></tr><tr><td align="left">49</td><td char="." align="char">37.33</td><td align="left">t-Butyldimethyl(10-octylundec-10-enyloxy) silane</td><td align="left">C<sub>25</sub>H<sub>52</sub>OSi</td><td char="." align="char">3.63</td></tr><tr><td align="left">50</td><td char="." align="char">37.45</td><td align="left">15-Isopropenyl-oxacyclopentadecan-2-one</td><td align="left">C<sub>20</sub>H<sub>38</sub>O<sub>2</sub>Si</td><td char="." align="char">0.24</td></tr><tr><td align="left">51</td><td char="." align="char">37.696</td><td align="left">Hexakis(fluorodimethylsilyl)benzebe</td><td align="left">C<sub>18</sub>H<sub>36</sub>F<sub>6</sub>Si<sub>6</sub></td><td char="." align="char">0.5</td></tr><tr><td align="left">52</td><td char="." align="char">37.942</td><td align="left">1,4-benzenediacetonitrile, .alpha.,.alpha.&#x02018;-bis[[4-(diethylamino)-2-methoxyphenyl]methylene</td><td align="left">C<sub>34</sub>H<sub>38</sub>N<sub>4</sub>O<sub>2</sub></td><td char="." align="char">3.22</td></tr><tr><td align="left">53</td><td char="." align="char">38.068</td><td align="left">Linoleic&#x000a0;<italic>acid</italic>&#x000a0;(LA)</td><td align="left">C<sub>18</sub>H<sub>32</sub>O<sub>2</sub></td><td char="." align="char">1.65</td></tr><tr><td align="left">54</td><td char="." align="char">38.76</td><td align="left">Monopalmitoylglycerol</td><td align="left">C<sub>19</sub>H<sub>38</sub>O<sub>4</sub></td><td char="." align="char">
<bold>9.79</bold>
</td></tr><tr><td align="left">55</td><td char="." align="char">39.184</td><td align="left">3,7,11,15-tetramethylhexadecan-1,3-diol</td><td align="left">C<sub>20</sub>H<sub><italic>42</italic></sub>O<sub>2</sub></td><td char="." align="char">1.51</td></tr><tr><td align="left">56</td><td char="." align="char">39.361</td><td align="left">Erythro-Pentonic acid, 2-deoxy-3,4,5-tris-OH</td><td align="left">C<sub>17</sub>H<sub>42</sub>O<sub>5</sub></td><td char="." align="char">0.65</td></tr><tr><td align="left">57</td><td char="." align="char">39.487</td><td align="left">1-Monoferuloylglycerol</td><td align="left">C<sub>13</sub>H<sub>16</sub>O<sub>6</sub></td><td char="." align="char">0.26</td></tr><tr><td align="left">58</td><td char="." align="char">39.75</td><td align="left">5,8,11-Eicosatriynoic acid</td><td align="left">C<sub>20</sub>H<sub>28</sub>O<sub>2</sub></td><td char="." align="char">2.43</td></tr><tr><td align="left">59</td><td char="." align="char">40.048</td><td align="left">Tofisopam</td><td align="left">C<sub>22</sub>H<sub>26</sub>N<sub>2</sub>O<sub>4</sub></td><td char="." align="char">0.7</td></tr><tr><td align="left">60</td><td char="." align="char">40.271</td><td align="left">Arachidonic acid</td><td align="left">C<sub>20</sub>H<sub>24</sub>O<sub>2</sub></td><td char="." align="char">0.48</td></tr><tr><td align="left">61</td><td char="." align="char">40.397</td><td align="left">Silane, diethyloctyloxytetradecyloxy</td><td align="left">C<sub>26</sub>H<sub>56</sub>O<sub>2</sub>Si</td><td char="." align="char">1.02</td></tr><tr><td align="left">62</td><td char="." align="char">40.494</td><td align="left">2-Monostearin</td><td align="left">C<sub>21</sub>H<sub>42</sub>O<sub>4</sub></td><td char="." align="char">0.23</td></tr><tr><td align="left">63</td><td char="." align="char">40.614</td><td align="left">1-Monooleoylglycerol</td><td align="left">C<sub>21</sub>H<sub>40</sub>O<sub>4</sub></td><td char="." align="char">1.07</td></tr><tr><td align="left">64</td><td char="." align="char">40.706</td><td align="left">Genistein</td><td align="left">C<sub>15</sub>H<sub>10</sub>O<sub>5</sub></td><td char="." align="char">0.55</td></tr><tr><td align="left">65</td><td char="." align="char">40.774</td><td align="left">Catechine</td><td align="left">C<sub>15</sub>H<sub>14</sub>O<sub>6</sub></td><td char="." align="char">2.33</td></tr><tr><td align="left">66</td><td char="." align="char">40.826</td><td align="left">Glycerol monostearate</td><td align="left">C<sub>21</sub>H<sub>42</sub>O<sub>4</sub></td><td char="." align="char">2.63</td></tr><tr><td align="left">67</td><td char="." align="char">40.917</td><td align="left">D-Glucopyranuronic acid</td><td align="left">C<sub>6</sub>H<sub>10</sub>O<sub>7</sub></td><td char="." align="char">0.99</td></tr><tr><td align="left">68</td><td char="." align="char">41.106</td><td align="left">[(2-{3,4-Bisoxy]phenyl}- oxy]-3,4-dihydro-2&#x000a0;H-chromen-7-yl-oxysilane</td><td align="left">C<sub>30</sub>H<sub>54</sub>O<sub>6</sub>Si<sub>5</sub></td><td char="." align="char">1.74</td></tr><tr><td align="left">69</td><td char="." align="char">41.244</td><td align="left">1,6-Dihydroxy-8-methoxy-3-methylanthraquinone</td><td align="left">C<sub>16</sub>H<sub>12</sub>O<sub>5</sub></td><td char="." align="char">
<bold>9.12</bold>
</td></tr><tr><td align="left">70</td><td char="." align="char">41.318</td><td align="left">(4-(1-(3,5-Dimethyl-4phenyl)-1,3-dimethylbutyl)-2,6-dimethylphenoxysilane</td><td align="left">C<sub>28</sub>H<sub>46</sub>O<sub>2</sub>Si<sub>2</sub></td><td char="." align="char">0.6</td></tr><tr><td align="left">71</td><td char="." align="char">41.358</td><td align="left">[(2-{3,4-Bisoxy]phenyl}-3,5-bis-3,4-dihydro-2&#x000a0;H-chromen-7-yl)oxy](trimethyl)silane</td><td align="left">C<sub>30</sub>H<sub>54</sub>O<sub>6</sub>Si<sub><bold><italic>5</italic></bold></sub></td><td char="." align="char">1.21</td></tr><tr><td align="left">72</td><td char="." align="char">41.427</td><td align="left">17.alpha.-Methyltestosterone</td><td align="left">C<sub>20</sub>H<sub>30</sub>O<sub>2</sub></td><td char="." align="char">1.14</td></tr><tr><td align="left">73</td><td char="." align="char">41.621</td><td align="left">4-Androsten-4-ol-3,17-dionel</td><td align="left">C<sub>19</sub>H<sub>26</sub>O<sub>3</sub></td><td char="." align="char">0.32</td></tr><tr><td align="left">74</td><td char="." align="char">41.661</td><td align="left">Monoketal adduct</td><td align="left">C29H32O5</td><td char="." align="char">0.39</td></tr><tr><td align="left">75</td><td char="." align="char">42.296</td><td align="left">Saponarin</td><td align="left">C<sub>27</sub>H<sub>30</sub>O<sub>15</sub></td><td char="." align="char">0.24</td></tr><tr><td align="left">76</td><td char="." align="char">43.172</td><td align="left">3,5-Dihydroxybenzyl alcohol</td><td align="left">C<sub>7</sub>H<sub>8</sub>O<sub>3</sub></td><td char="." align="char">0.15</td></tr><tr><td align="left">77</td><td char="." align="char">43.698</td><td align="left">delta.(1)-Tetrahydrocannabinolic acid</td><td align="left">C<sub>22</sub>H<sub>30</sub>O<sub>4</sub></td><td char="." align="char">0.54</td></tr><tr><td align="left">78</td><td char="." align="char">43.784</td><td align="left"><p>17-(1,5-Dimethylhexyl)-10,13-dimethyl-3-styrylhexadecahydrocyclopenta[a]</p><p>phenanthren-2-one</p></td><td align="left">C35H52O</td><td char="." align="char">0.43</td></tr><tr><td align="left">79</td><td char="." align="char">44.036</td><td align="left">-unknown</td><td align="left"/><td char="." align="char">1.91</td></tr><tr><td align="left">80</td><td char="." align="char">44.665</td><td align="left">1,2,8-Trihydroxy-3-methoxy-6-methylanthraquinone</td><td align="left">C<sub>16</sub>H<sub>12</sub>O<sub>6</sub></td><td char="." align="char">0.66</td></tr><tr><td align="left">81</td><td char="." align="char">44.974</td><td align="left">Monoolein</td><td align="left">C<sub>21</sub>H<sub>40</sub>O<sub>4</sub></td><td char="." align="char">0.48</td></tr><tr><td align="left">82</td><td char="." align="char">45.592</td><td align="left">Homogentisic acid</td><td align="left">C<sub>8</sub>H<sub>8</sub>O<sub>4</sub></td><td char="." align="char">0.4</td></tr><tr><td align="left">83</td><td char="." align="char">45.712</td><td align="left">2,4-Imidazolidinedione, 5- oxy]phenyl]-3-methyl-5-phenyl</td><td align="left">C<sub>16</sub>H<sub>16</sub>N<sub>2</sub>O<sub>4</sub></td><td char="." align="char">0.54</td></tr><tr><td align="left">84</td><td char="." align="char">45.884</td><td align="left">Naringenin</td><td align="left">C<sub>15</sub>H<sub>12</sub>O<sub>5</sub></td><td char="." align="char">1.48</td></tr><tr><td align="left">85</td><td char="." align="char">46.205</td><td align="left">2-Oxabicyclo[3.3.0]octa-3,7-dien-6-one, 3-acetyl-4-methyl-1,5,7,8-tetrakis</td><td align="left">C<sub>22</sub>H<sub>42</sub>O<sub>7</sub></td><td char="." align="char">2.99</td></tr><tr><td align="left">86</td><td char="." align="char">46.519</td><td align="left">6-[Nonadecenyl]salicylic acid</td><td align="left">C<sub>26</sub>H<sub>42</sub>O<sub>3</sub></td><td char="." align="char">0.89</td></tr><tr><td align="left">87</td><td char="." align="char">47.074</td><td align="left">Octasiloxane, hexadecamethyl</td><td align="left">C<sub>16</sub>H<sub>50</sub>O<sub>7</sub></td><td char="." align="char">0.27</td></tr><tr><td align="left">88</td><td char="." align="char">47.944</td><td align="left">2-Monomyristin</td><td align="left">C<sub>17</sub>H<sub>34</sub>O<sub>4</sub></td><td char="." align="char">0.65</td></tr><tr><td align="left">89</td><td char="." align="char">49.552</td><td align="left">Heptasiloxane, tetradecamethyl ester</td><td align="left">C<sub>14</sub>H<sub>42</sub>O<sub>7</sub>Si<sub>7</sub></td><td char="." align="char">0.16</td></tr><tr><td align="left">90</td><td char="." align="char">49.855</td><td align="left">1-Monolinoleoylglycerol</td><td align="left">C<sub>27</sub>H<sub>54</sub>O<sub>4</sub></td><td char="." align="char">0.65</td></tr><tr><td align="left">
<bold>Total</bold>
</td><td align="left"/><td align="left"/><td align="left"/><td char="." align="char">
<bold>99.1</bold>
</td></tr></tbody></table></table-wrap>
</p></sec><sec id="Sec20"><title>HPLC analysis</title><p id="Par65">HPLC polyphenol analysis of the most active fraction (F5) in propolis revealed the presence of 14 phenolic acids and flavonoid compounds in the range of 117.36&#x02013;5657.66&#x000a0;&#x000b5;g/g. These compounds included 4 flavonoids (catechin, naringenin, taxifolin, and kaempferol) and 10 phenolic acids (gallic acid, chlorogenic acid, catechin, methyl gallate, caffeic acid, syringic acid, pyrocatechol, ellagic acid, coumaric acid, vanillin, and cinnamic acid). The biological activity of the propolis fraction contributed to the most abundant compounds, which included naringenin (5657.66&#x000a0;&#x000b5;g/g), gallic acid (5217.66&#x000a0;&#x000b5;g/g), taxifolin (5192.48&#x000a0;&#x000b5;g/g), pyrocatechol (2182.90&#x000a0;&#x000b5;g/g), and kaempferol (1029.27&#x000a0;&#x000b5;g/g), as shown in Table&#x000a0;<xref rid="Tab5" ref-type="table">5</xref>; Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">4</xref>.</p><p id="Par66">
<fig id="Fig5"><label>Fig. 4</label><caption><p>HPLC chromatogram of (<bold>A</bold>) reference standards polyphenol compounds and (<bold>B</bold>) fraction 5 in propolis with identified marker compounds. 1: gallic acid, 2: chlorogenic acid, 3: catechin, 4: methyl gallate, 5: coffeic acid, 6: syringic acid, 7: pyrocatechol, 8: ellagic acid, 9: coumaric acid, 10: vanillin, 11: naringenin, 12: taxifolin, 13: cinnamic acid, and 14: kaempferol.</p></caption><graphic xlink:href="41598_2025_773_Fig5_HTML" id="d33e3096"/></fig>
</p><p id="Par67">
<table-wrap id="Tab5"><label>Table 5</label><caption><p>Results of HPLC analysis of fraction 5.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Peak No.</th><th align="left" colspan="2">Retention time (RT)</th><th align="left" rowspan="2">Concentration (&#x000b5;g/g)</th><th align="left" rowspan="2">Identified compounds</th></tr><tr><th align="left">Standard</th><th align="left">Test</th></tr></thead><tbody><tr><td align="left">1.</td><td char="." align="char">3.263</td><td char="." align="char">3.334</td><td char="." align="char">
<bold>5217.66</bold>
</td><td align="left">
<bold>Gallic acid</bold>
</td></tr><tr><td align="left">2.</td><td char="." align="char">4.046</td><td char="." align="char">3.970</td><td char="." align="char">594.05</td><td align="left">Chlorogenic acid</td></tr><tr><td align="left">3.</td><td char="." align="char">4.475</td><td char="." align="char">4.460</td><td char="." align="char">1183.75</td><td align="left">Catechin</td></tr><tr><td align="left">4.</td><td char="." align="char">5.668</td><td char="." align="char">5.694</td><td char="." align="char">194.71</td><td align="left">Methyl gallate</td></tr><tr><td align="left">5.</td><td char="." align="char">5.974</td><td char="." align="char">5.993</td><td char="." align="char">121.32</td><td align="left">Coffeic acid</td></tr><tr><td align="left">6.</td><td char="." align="char">6.513</td><td char="." align="char">6.504</td><td char="." align="char">153.70</td><td align="left">Syringic acid</td></tr><tr><td align="left">7.</td><td char="." align="char">7.193</td><td char="." align="char">7.328</td><td char="." align="char">
<bold>2182.90</bold>
</td><td align="left">
<bold>Pyrocatechol</bold>
</td></tr><tr><td align="left">8.</td><td char="." align="char">8.147</td><td char="." align="char">8.301</td><td char="." align="char">336.62</td><td align="left">Ellagic acid</td></tr><tr><td align="left">9.</td><td char="." align="char">9.139</td><td char="." align="char">9.149</td><td char="." align="char">117.36</td><td align="left">Coumaric acid</td></tr><tr><td align="left">10.</td><td char="." align="char">9.894</td><td char="." align="char">9.848</td><td char="." align="char">154.83</td><td align="left">Vanillin</td></tr><tr><td align="left">11.</td><td char="." align="char">10.218</td><td char="." align="char">10.223</td><td char="." align="char">
<bold>5657.66</bold>
</td><td align="left">
<bold>Naringenin</bold>
</td></tr><tr><td align="left">12.</td><td char="." align="char">13.431</td><td char="." align="char">13.019</td><td char="." align="char">
<bold>5192.48</bold>
</td><td align="left">
<bold>Taxifolin</bold>
</td></tr><tr><td align="left">13.</td><td char="." align="char">14.332</td><td char="." align="char">14.590</td><td char="." align="char">322.58</td><td align="left">Cinnamic acid</td></tr><tr><td align="left">14.</td><td char="." align="char">14.715</td><td char="." align="char">14.907</td><td char="." align="char">
<bold>1029.27</bold>
</td><td align="left">
<bold>Kaempferol</bold>
</td></tr></tbody></table></table-wrap>
</p></sec></sec></sec><sec id="Sec21"><title>Discussion</title><p id="Par71">Propolis (bee glue) is as old as honey and has been used by humans as a traditional medicine since antiquity. There are many records recommending its utilization in medication by the ancient Egyptians, Persians, and Romans<sup><xref ref-type="bibr" rid="CR33">33</xref></sup>. The results of the in vitro antimicrobial assay indicated that EEP inhibited the growth of Gram-positive CON <italic>S. saprophyticus</italic> bacteria and <italic>Candida albicans</italic> yeast better than Gram-negative <italic>P. aeruginosa</italic>,<italic> K. pneumonia</italic>, and <italic>E.</italic> coli bacteria. This is explained by the presence of the outer membrane in the Gram-negative bacteria<sup><xref ref-type="bibr" rid="CR14">14</xref>,<xref ref-type="bibr" rid="CR34">34</xref></sup>. The low sensitivity of <italic>E. coli</italic> toward propolis has also been reported by many researchers, as this bacterium showed either very low sensitivity or a total lack of sensitivity to propolis<sup><xref ref-type="bibr" rid="CR35">35</xref>,<xref ref-type="bibr" rid="CR36">36</xref></sup>. Moreover, a previous study by Taher<sup><xref ref-type="bibr" rid="CR37">37</xref></sup> supported our results and reported that MDR <italic>K. pneumoniae</italic> was sensitive to Iraq EEP with an average inhibition zone of 12.6&#x000a0;mm at a concentration of 100&#x000a0;mg/ml, while another study by Al-Ani et al.<sup><xref ref-type="bibr" rid="CR22">22</xref></sup> found <italic>P. aeruginosa</italic> displayed high resistance to European propolis, which is in contrast to our results. In the current study, the MIC value of EEP on <italic>C. albicans</italic> and <italic>S. saprophyticus</italic> was 3.51 and 3.90&#x000a0;mg/ml, respectively, while against <italic>P. aeruginosa</italic>,<italic> K. pneumonia</italic>, and <italic>E.</italic> coli were in the range of 14.66&#x02013;31.25&#x000a0;mg/ml, which were higher than a previous study of ours on Turkish propolis that reported MIC values in the range of 0.185-3.50&#x000a0;mg/ml on <italic>K. pneumonia</italic>, <italic>P. aeruginosa</italic>,<italic> S. aureus</italic>, and <italic>C. albicans</italic><sup><xref ref-type="bibr" rid="CR9">9</xref></sup>. On the other hand, previous studies have concluded that natural honey can inhibit the growth of some pathogenic bacteria with varying inhibition degrees<sup><xref ref-type="bibr" rid="CR9">9</xref>,<xref ref-type="bibr" rid="CR38">38</xref>,<xref ref-type="bibr" rid="CR39">39</xref></sup>, while honey in our study showed no effect on the isolated pathogens, which may be due to the extreme resistance of urinary pathogens to antibiotics.</p><p id="Par72">The addition of propolis to honey resulted in an increase in IZDs of EEP from 12.85 to 21.67&#x000a0;mm to 16.58&#x02013;26.00&#x000a0;mm in the EEP-Honey mixture as well as a decrease in the MIC values of EEP from 3.51 to 31.25&#x000a0;mg/ml to 0.95&#x02013;7.81&#x000a0;mg/ml in the EEP-Honey mixture, where significant synergy has been recorded. Basically, the antimicrobial synergism of propolis and honey may be related to the synergistic effect of their various flavonoids and phenolic compounds, which have been supported by previous studies<sup><xref ref-type="bibr" rid="CR24">24</xref>,<xref ref-type="bibr" rid="CR29">29</xref>,<xref ref-type="bibr" rid="CR40">40</xref></sup>. In line with our findings, another study by Hamouda et al.<sup><xref ref-type="bibr" rid="CR41">41</xref></sup> reported the good antimicrobial effect of Egyptian fennel honey and EEP against 19 strains of methicillin-resistant <italic>Staphylococcus aureus</italic> (MRSA), where honey and EEP showed a synergistic effect when added together (MIC&#x02009;=&#x02009;7.84&#x000a0;mg/ml).</p><p id="Par73">Propolis fractionation was performed using a three-step sequential extraction: first with 70% ethanol, followed by the use of four solvent systems (petroleum ether, chloroform, ethyl acetate, and n-butanol), where ethyl acetate was the best solvent for the extraction of the antimicrobial substance from EEP. These results were supported by the study of Bouaroura et al.<sup><xref ref-type="bibr" rid="CR42">42</xref></sup> using Algerian propolis, as the ethyl acetate extract displayed increased contents of antimicrobial substances. Further, findings in the Chen et al.<sup><xref ref-type="bibr" rid="CR43">43</xref></sup> study reported the ethyl acetate fraction showed the highest total phenolic and flavonoid contents, which have potential antioxidant and antimicrobial activity, compared to the n-butanol fraction, chloroform fraction, and petroleum ether fractions. The standard protocols for chemical fractionation and bioactivity-guided chemical analysis were used to identify the bioactive ethyl acetate fraction, as it contained the highest polyphenol contents<sup><xref ref-type="bibr" rid="CR44">44</xref></sup>. The third step was carried out using a VLC silica gel column, as the ethyl acetate EEP fraction was separated into seven further fractions named F1, F2, F3, F4, F5, F6, and F7, on which the pure F5 fraction gave the best antimicrobial activity against MDR uropathogens and was subsequently analyzed by GC-MS and HPLC.</p><p id="Par74">The GC-MS analysis of the F5 fraction revealed the presence of 90 chemical compounds at different concentrations, including phenolic acids, flavonoids, terpenoids, alkaloids, steroids, organic acids, fatty acids, hydrocarbon esters, ketones, and sugars. These compounds act synergistically and are responsible for the therapeutical and pharmacological properties of propolis<sup><xref ref-type="bibr" rid="CR12">12</xref>,<xref ref-type="bibr" rid="CR45">45</xref></sup>. Polyphenol compounds (phenolic acids and flavonoids) are considered the main antimicrobial and bioactive antioxidant components in propolis<sup><xref ref-type="bibr" rid="CR9">9</xref>,<xref ref-type="bibr" rid="CR46">46</xref></sup>. In our study, caffeic acid esters are strong bactericidal agents and inhibit bacterial growth by disrupting membrane permeability or through oxidative stress mechanisms<sup><xref ref-type="bibr" rid="CR47">47</xref>,<xref ref-type="bibr" rid="CR48">48</xref></sup>. Also, 1,6-Dihydroxy-8-methoxy-3-methylanthraquinone and monopalmitoylglycerol were reported in propolis in Kurek-G&#x000f3;recka et al.<sup><xref ref-type="bibr" rid="CR48">48</xref></sup> and Shi et al.<sup><xref ref-type="bibr" rid="CR49">49</xref></sup>. studies with anti-inflammatory properties. Further, 4-hydroxycinnamic acid is a derivative of cinnamic acid and disrupts the outer membrane of Gram-negative bacteria, causing cytoplasmic leakage<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>.</p><p id="Par75">The HPLC analysis of the most active propolis fraction (F5) resulted in the presence of 14 polyphenol compounds, including naringenin, gallic acid, taxifolin, pyrocatechol, kaempferol, catechin, chlorogenic acid, methyl gallate, coffeic acid, syringic acid, ellagic acid, coumaric acid, vanillin, and cinnamic acid, which contributed to the antimicrobial activities of propolis. Previous studies on African, Asian, and European propolis concluded that propolis contains predominantly polyphenols such as naringenin, galangin, pinocembrin, apigenin, pinobanksin, quercetin, cinnamic acid and its esters, aromatic acids and their esters, kaempferol, chrysin, p-coumaric acid, cinnamyl caffeate, cinnamylidene acetic acid, and caffeic acid<sup><xref ref-type="bibr" rid="CR46">46</xref>,<xref ref-type="bibr" rid="CR51">51</xref>,<xref ref-type="bibr" rid="CR52">52</xref></sup>. The composition of propolis varies depending on the plant&#x02019;s origin, geographical location, and collection seasons<sup><xref ref-type="bibr" rid="CR9">9</xref>,<xref ref-type="bibr" rid="CR22">22</xref></sup>.</p><p id="Par76">The high concentration of naringenin and taxifolin flavonoids in our study may be the main reason for the significant inhibitory effect of F5 fraction against MDR uropathogens, especially <italic>P. aeruginosa</italic> (IZD&#x02009;=&#x02009;30.33&#x000a0;mm), where Vandeputte et al.<sup><xref ref-type="bibr" rid="CR53">53</xref></sup> and Shariati et al.<sup><xref ref-type="bibr" rid="CR54">54</xref></sup> studies reported the inhibitory effect of naringenin and taxifolin on the expression of various quorum sensing (QS) controlled genes in <italic>P. aeruginosa</italic> and thus reduce the virulence factors of pathogenic bacteria. Furthermore, naringenin possesses anti-staphylococcal activity<sup><xref ref-type="bibr" rid="CR55">55</xref>,<xref ref-type="bibr" rid="CR56">56</xref></sup> and antibacterial properties against <italic>E. coli</italic><sup><xref ref-type="bibr" rid="CR56">56</xref></sup>. Likewise, some phenolic acids, such as cinnamic acid and its derivatives, have anti-QS activity and inhibit bacteria by damaging the cell membrane, inhibiting ATPases, cell division, and biofilm formation<sup><xref ref-type="bibr" rid="CR57">57</xref></sup>. Also, other phenolic acids like ferulic, caffeic, and chlorogenic acids are effective in preventing bacterial adhesion<sup><xref ref-type="bibr" rid="CR58">58</xref>,<xref ref-type="bibr" rid="CR59">59</xref></sup>; while gallic acid inhibits efflux pump mechanisms in MDR <italic>Staphylococcus</italic> spp. and <italic>E. coli</italic> strains. The mixture of phenolic catechin and vanillic acids possesses antioxidant and antimicrobial synergy and is effective in preventing cell adhesion and biofilm formation in uropathogenic <italic>E. coli</italic> compared to single compounds or nitrofurantoin antibiotics<sup><xref ref-type="bibr" rid="CR60">60</xref></sup>. Accordingly, the combination of many active components in propolis and their presence in various proportions prevents the occurrence of bacterial resistance<sup><xref ref-type="bibr" rid="CR48">48</xref>,<xref ref-type="bibr" rid="CR61">61</xref>,<xref ref-type="bibr" rid="CR62">62</xref></sup>. Finally, the design of the study and the important findings were presented as a schematic drawing in Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">5</xref>.</p><p id="Par77">
<fig id="Fig6"><label>Fig. 5</label><caption><p>A Schematic drawing illustrating the design of the study and the important findings.</p></caption><graphic xlink:href="41598_2025_773_Fig6_HTML" id="d33e3585"/></fig>
</p></sec><sec id="Sec22"><title>Conclusion</title><p id="Par79">Over recent years, the increasing empiric treatment with antibiotics in UTIs and the emergence of MDR urinary pathogens have stimulated the use of traditional medicine and attempts to improve it for therapeutic use, such as propolis, honey, and their mixtures. In the current study, propolis inhibited all MDR uropathogens, while honey did not. Interestingly, the combination of propolis and honey showed a great synergistic effect with a significant increase in the antimicrobial activity of propolis, which was expressed by reducing the MIC value of EEP for all uropathogens by approximately 4&#x02013;8 folds. Propolis fractionation was carried out, as ethyl acetate was the best solvent to extract the antimicrobial substances from EEP. The ethyl acetate EEP fraction was further fractionated using a VLC silica gel column to get seven fractions, of which the F5 fraction was the most active with the best antimicrobial activity against MDR uropathogens and was analyzed by GC-MS and HPLC. HPLC analysis of the polyphenols in the F5 fraction of propolis revealed the presence of 14 phenolic acids and flavonoid compounds, where the most abundant compounds were naringenin, gallic acid, taxifolin, and pyrocatechol. GC-MS analysis indicated the presence of many constituents in different concentrations, including phenolic acids, flavonoids, terpenoids, and alkaloids, which are responsible for the biological and pharmaceutical properties of propolis. Thus, the combination of many active ingredients in propolis and their presence in various proportions prevents bacterial resistance.</p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>CON</term><def><p id="Par2">Coagulase negative</p></def></def-item><def-item><term>EEP</term><def><p id="Par3">Ethanolic extract of propolis</p></def></def-item><def-item><term>ESBL</term><def><p id="Par4">Extended spectrum &#x003b2;-lactam antibiotic</p></def></def-item><def-item><term>F1</term><def><p id="Par5">F7:Fraction 1:fraction 7</p></def></def-item><def-item><term>GC-MS</term><def><p id="Par6">Gas chromatography-mass spectrometry</p></def></def-item><def-item><term>HPLC</term><def><p id="Par7">High-performance liquid chromatography</p></def></def-item><def-item><term>IZD</term><def><p id="Par8">Inhibition zone diameter</p></def></def-item><def-item><term>MDR</term><def><p id="Par9">Multidrug-resistant</p></def></def-item><def-item><term>MIC</term><def><p id="Par10">Minimum inhibitory concentration</p></def></def-item><def-item><term>MRSA</term><def><p id="Par11">Methicillin-resistant Staphylococcus aureus</p></def></def-item><def-item><term>RT</term><def><p id="Par12">Retention time</p></def></def-item><def-item><term>SE</term><def><p id="Par13">Standard error</p></def></def-item><def-item><term>UTI</term><def><p id="Par14">Urinary tract infection</p></def></def-item><def-item><term>VLC</term><def><p id="Par15">Vacuum liquid chromatography</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Publisher&#x02019;s note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>The authors would like to express their deep and sincere gratitude to Dr. Heba Sayed Mostafa, Associate Professor of Food Science, Faculty of Agriculture, Cairo University, Egypt, for her assistance in the statistical analysis process that supported the significance of the observed differences in the results.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>NMS, MMA, and AAE developed and supervised the work. AKH, NMS, MMA, and AAE designed the study. MMA performed the MIC test. AAE performed the phytochemical analysis of propolis. AKH collected the uropathogens, performed the antimicrobial and synergy experimental work, analyzed and interpreted the data, and wrote the first draft of the manuscript. NMS reviewed and editing the initial and final drafts of the manuscript. All authors read and approved the final manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>Open access funding provided by The Science, Technology &#x00026; Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB).</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>All information created or analyzed during the present study are included in the manuscript.</p></notes><notes><title>Declarations</title><notes id="FPar10" notes-type="COI-statement"><title>Competing interests</title><p id="Par80">The authors declare no competing interests.</p></notes><notes><title> Ethics approval and consent to participate</title><p>Not applicable. This manuscript does not refer to or imply the use of any animal or human data or tissues.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name><surname>McLellan</surname><given-names>LK</given-names></name><name><surname>Hunstad</surname><given-names>DA</given-names></name></person-group><article-title>Urinary tract infection: pathogenesis and outlook</article-title><source>Trends Mol. Med.</source><year>2016</year><volume>22</volume><issue>11</issue><fpage>946</fpage><lpage>957</lpage><pub-id pub-id-type="doi">10.1016/j.molmed.2016.09.003</pub-id><pub-id pub-id-type="pmid">27692880</pub-id>
</element-citation><mixed-citation id="mc-CR1" publication-type="journal">McLellan, L. K. &#x00026; Hunstad, D. A. Urinary tract infection: pathogenesis and outlook. <italic>Trends Mol. Med.</italic><bold>22</bold> (11), 946&#x02013;957. 10.1016/j.molmed.2016.09.003 (2016).<pub-id pub-id-type="pmid">27692880</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Mlugu</surname><given-names>EM</given-names></name><name><surname>Mohamedi</surname><given-names>JA</given-names></name><name><surname>Sangeda</surname><given-names>RZ</given-names></name><name><surname>Mwambete</surname><given-names>KD</given-names></name></person-group><article-title>Prevalence of urinary tract infection and antimicrobial resistance patterns of uropathogens with biofilm forming capacity among outpatients in Morogoro, Tanzania: a cross-sectional study</article-title><source>BMC Infect. Dis.</source><year>2023</year><volume>23</volume><issue>1</issue><fpage>660</fpage><pub-id pub-id-type="doi">10.1186/s12879-023-08641-x</pub-id><pub-id pub-id-type="pmid">37798713</pub-id>
</element-citation><mixed-citation id="mc-CR2" publication-type="journal">Mlugu, E. M., Mohamedi, J. A., Sangeda, R. Z. &#x00026; Mwambete, K. D. Prevalence of urinary tract infection and antimicrobial resistance patterns of uropathogens with biofilm forming capacity among outpatients in Morogoro, Tanzania: a cross-sectional study. <italic>BMC Infect. Dis.</italic><bold>23</bold> (1), 660. 10.1186/s12879-023-08641-x (2023).<pub-id pub-id-type="pmid">37798713</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>Galiczewski</surname><given-names>JM</given-names></name><name><surname>Shurpin</surname><given-names>KM</given-names></name></person-group><article-title>An intervention to improve the catheter associated urinary tract infection rate in a medical intensive care unit: direct observation of catheter insertion procedure</article-title><source>Intensive Crit. Care Nurs.</source><year>2017</year><volume>40</volume><fpage>26</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1016/j.iccn.2016.12.003</pub-id><pub-id pub-id-type="pmid">28237090</pub-id>
</element-citation><mixed-citation id="mc-CR3" publication-type="journal">Galiczewski, J. M. &#x00026; Shurpin, K. M. An intervention to improve the catheter associated urinary tract infection rate in a medical intensive care unit: direct observation of catheter insertion procedure. <italic>Intensive Crit. Care Nurs.</italic><bold>40</bold>, 26&#x02013;34. 10.1016/j.iccn.2016.12.003 (2017).<pub-id pub-id-type="pmid">28237090</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>Waller</surname><given-names>TA</given-names></name><name><surname>Pantin</surname><given-names>SA</given-names></name><name><surname>Yenior</surname><given-names>AL</given-names></name><name><surname>Pujalte</surname><given-names>GG</given-names></name></person-group><article-title>Urinary tract infection antibiotic resistance in the united States</article-title><source>Prim. Care: Clin. Office Pract.</source><year>2018</year><volume>45</volume><issue>3</issue><fpage>455</fpage><lpage>466</lpage><pub-id pub-id-type="doi">10.1016/j.pop.2018.05.005</pub-id></element-citation><mixed-citation id="mc-CR4" publication-type="journal">Waller, T. A., Pantin, S. A., Yenior, A. L. &#x00026; Pujalte, G. G. Urinary tract infection antibiotic resistance in the united States. <italic>Prim. Care: Clin. Office Pract.</italic><bold>45</bold> (3), 455&#x02013;466. 10.1016/j.pop.2018.05.005 (2018).</mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>W</given-names></name><etal/></person-group><article-title>Rapid identification and antimicrobial susceptibility testing for urinary tract pathogens by direct analysis of urine samples using a MALDI-TOF MS-based combined protocol</article-title><source>Front. Microbiol.</source><year>2019</year><volume>10</volume><fpage>458039</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2019.01182</pub-id></element-citation><mixed-citation id="mc-CR5" publication-type="journal">Li, W. et al. Rapid identification and antimicrobial susceptibility testing for urinary tract pathogens by direct analysis of urine samples using a MALDI-TOF MS-based combined protocol. <italic>Front. Microbiol.</italic><bold>10</bold>, 458039. 10.3389/fmicb.2019.01182 (2019).</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>Helmy</surname><given-names>AK</given-names></name><name><surname>Sidkey</surname><given-names>NM</given-names></name><name><surname>El-Badawy</surname><given-names>RE</given-names></name><name><surname>Hegazi</surname><given-names>AG</given-names></name></person-group><article-title>Emergence of microbial infections in some hospitals of Cairo, Egypt: studying their corresponding antimicrobial resistance profiles</article-title><source>BMC Infect. Dis.</source><year>2023</year><volume>23</volume><issue>1</issue><fpage>424</fpage><pub-id pub-id-type="doi">10.1186/s12879-023-08397-4</pub-id><pub-id pub-id-type="pmid">37349674</pub-id>
</element-citation><mixed-citation id="mc-CR6" publication-type="journal">Helmy, A. K., Sidkey, N. M., El-Badawy, R. E. &#x00026; Hegazi, A. G. Emergence of microbial infections in some hospitals of Cairo, Egypt: studying their corresponding antimicrobial resistance profiles. <italic>BMC Infect. Dis.</italic><bold>23</bold> (1), 424. 10.1186/s12879-023-08397-4 (2023).<pub-id pub-id-type="pmid">37349674</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><mixed-citation publication-type="other">World Health Organization (WHO). <italic>Antibacterial Agents in Clinical Development: an Analysis of the Antibacterial Clinical Development Pipeline, Including Tuberculosis</italic> (World Health Organization, 2017). <ext-link ext-link-type="uri" xlink:href="https://iris.who.int/handle/10665/258965">https://iris.who.int/handle/10665/258965</ext-link>WHO/EMP/IAU/2017.12.</mixed-citation></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name><surname>D&#x02019;Andrea</surname><given-names>MM</given-names></name><name><surname>Fraziano</surname><given-names>M</given-names></name><name><surname>Thaller</surname><given-names>MC</given-names></name><name><surname>Rossolini</surname><given-names>GM</given-names></name></person-group><article-title>The urgent need for novel antimicrobial agents and strategies to fight antibiotic resistance</article-title><source>Antibiotics</source><year>2019</year><volume>8</volume><issue>4</issue><fpage>254</fpage><pub-id pub-id-type="doi">10.3390/antibiotics8040254</pub-id><pub-id pub-id-type="pmid">31817707</pub-id>
</element-citation><mixed-citation id="mc-CR8" publication-type="journal">D&#x02019;Andrea, M. M., Fraziano, M., Thaller, M. C. &#x00026; Rossolini, G. M. The urgent need for novel antimicrobial agents and strategies to fight antibiotic resistance. <italic>Antibiotics</italic><bold>8</bold> (4), 254. 10.3390/antibiotics8040254 (2019).<pub-id pub-id-type="pmid">31817707</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><mixed-citation publication-type="other">Helmy, A. K., Hegazi, A. G. &#x00026; Sidkey, N. M. Antimicrobial activity of some honeybee products on Multidrug-Resistant secondary microbial infection from COVID-19 patients. <italic>Egypt J. Hosp. Med.</italic><bold>92</bold> (1). 10.21608/EJHM.2023.313899 (2023).</mixed-citation></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Bankova</surname><given-names>V</given-names></name></person-group><article-title>Chemical diversity of propolis and the problem of standardization</article-title><source>J. Ethnopharmacol.</source><year>2005</year><volume>100</volume><issue>1&#x02013;2</issue><fpage>114</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2005.05.004</pub-id><pub-id pub-id-type="pmid">15993016</pub-id>
</element-citation><mixed-citation id="mc-CR10" publication-type="journal">Bankova, V. Chemical diversity of propolis and the problem of standardization. <italic>J. Ethnopharmacol.</italic><bold>100</bold> (1&#x02013;2), 114&#x02013;117. 10.1016/j.jep.2005.05.004 (2005).<pub-id pub-id-type="pmid">15993016</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name><surname>Tosic</surname><given-names>S</given-names></name><name><surname>Stojanovic</surname><given-names>G</given-names></name><name><surname>Mitic</surname><given-names>S</given-names></name><name><surname>Pavlovic</surname><given-names>A</given-names></name><name><surname>Alagic</surname><given-names>S</given-names></name></person-group><article-title>Mineral composition of selected Serbian propolis samples</article-title><source>J. Apic. Sci.</source><year>2017</year><volume>61</volume><issue>1</issue><fpage>5</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1515/jas-2017-0001</pub-id></element-citation><mixed-citation id="mc-CR11" publication-type="journal">Tosic, S., Stojanovic, G., Mitic, S., Pavlovic, A. &#x00026; Alagic, S. Mineral composition of selected Serbian propolis samples. <italic>J. Apic. Sci.</italic><bold>61</bold> (1), 5&#x02013;15. 10.1515/jas-2017-0001 (2017).</mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Anjum</surname><given-names>SI</given-names></name><etal/></person-group><article-title>Composition and functional properties of propolis (bee glue): A review</article-title><source>Saudi J. Biol. Sci.</source><year>2019</year><volume>26</volume><issue>7</issue><fpage>1695</fpage><lpage>1703</lpage><pub-id pub-id-type="doi">10.1016/j.sjbs.2018.08.013</pub-id><pub-id pub-id-type="pmid">31762646</pub-id>
</element-citation><mixed-citation id="mc-CR12" publication-type="journal">Anjum, S. I. et al. Composition and functional properties of propolis (bee glue): A review. <italic>Saudi J. Biol. Sci.</italic><bold>26</bold> (7), 1695&#x02013;1703. 10.1016/j.sjbs.2018.08.013 (2019).<pub-id pub-id-type="pmid">31762646</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Irigoiti</surname><given-names>Y</given-names></name><etal/></person-group><article-title>The use of propolis as a functional food ingredient: A review</article-title><source>Trends Food Sci. Technol.</source><year>2021</year><volume>115</volume><fpage>297</fpage><lpage>306</lpage><pub-id pub-id-type="doi">10.1016/j.tifs.2021.06.041</pub-id></element-citation><mixed-citation id="mc-CR13" publication-type="journal">Irigoiti, Y. et al. The use of propolis as a functional food ingredient: A review. <italic>Trends Food Sci. Technol.</italic><bold>115</bold>, 297&#x02013;306. 10.1016/j.tifs.2021.06.041 (2021).</mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><mixed-citation publication-type="other">Sa-Eed, A. et al. In vitro antimicrobial activity of crude propolis extracts and fractions. <italic>FEMS Microbes</italic>. <bold>4</bold>10.1093/femsmc/xtad010 (2023).</mixed-citation></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>Yosri</surname><given-names>N</given-names></name><etal/></person-group><article-title>Anti-viral and Immunomodulatory properties of propolis: chemical diversity, Pharmacological properties, preclinical and clinical applications, and in Silico potential against SARS-CoV-2</article-title><source>Foods</source><year>2021</year><volume>10</volume><issue>8</issue><fpage>1776</fpage><pub-id pub-id-type="doi">10.3390/foods10081776</pub-id><pub-id pub-id-type="pmid">34441553</pub-id>
</element-citation><mixed-citation id="mc-CR15" publication-type="journal">Yosri, N. et al. Anti-viral and Immunomodulatory properties of propolis: chemical diversity, Pharmacological properties, preclinical and clinical applications, and in Silico potential against SARS-CoV-2. <italic>Foods</italic><bold>10</bold> (8), 1776. 10.3390/foods10081776 (2021).<pub-id pub-id-type="pmid">34441553</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name><surname>Negri</surname><given-names>G</given-names></name><etal/></person-group><article-title>Antiviral activity of red propolis against herpes simplex virus-1</article-title><source>Brazilian J. Pharm. Sci.</source><year>2024</year><volume>60</volume><fpage>e23746</fpage><pub-id pub-id-type="doi">10.1590/s2175-97902024e23746</pub-id></element-citation><mixed-citation id="mc-CR16" publication-type="journal">Negri, G. et al. Antiviral activity of red propolis against herpes simplex virus-1. <italic>Brazilian J. Pharm. Sci.</italic><bold>60</bold>, e23746. 10.1590/s2175-97902024e23746 (2024).</mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><mixed-citation publication-type="other">Abduh, M. Y., Shafitri, T. R. &#x00026; Elfahmi, E. Chemical profiling, bioactive compounds, antioxidant, and anti-inflammatory activities of Indonesian propolis extract produced by Tetragonula laeviceps. <italic>Heliyon</italic><bold>10</bold> (19). 10.1016/j.heliyon.2024.e38736 (2024).</mixed-citation></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name><surname>Nichitoi</surname><given-names>MM</given-names></name><etal/></person-group><article-title>Polyphenolics profile effects upon the antioxidant and antimicrobial activity of propolis extracts</article-title><source>Sci. Rep.</source><year>2021</year><volume>11</volume><issue>1</issue><fpage>20113</fpage><pub-id pub-id-type="doi">10.1038/s41598-021-97130-9</pub-id><pub-id pub-id-type="pmid">34635677</pub-id>
</element-citation><mixed-citation id="mc-CR18" publication-type="journal">Nichitoi, M. M. et al. Polyphenolics profile effects upon the antioxidant and antimicrobial activity of propolis extracts. <italic>Sci. Rep.</italic><bold>11</bold> (1), 20113. 10.1038/s41598-021-97130-9 (2021).<pub-id pub-id-type="pmid">34635677</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Shaker</surname><given-names>SA</given-names></name><etal/></person-group><article-title>Propolis-loaded nanostructured lipid carriers halt breast cancer progression through miRNA-223 related pathways: an in-vitro/in-vivo experiment</article-title><source>Sci. Rep.</source><year>2023</year><volume>13</volume><issue>1</issue><fpage>15752</fpage><pub-id pub-id-type="doi">10.1038/s41598-023-42709-7</pub-id><pub-id pub-id-type="pmid">37735586</pub-id>
</element-citation><mixed-citation id="mc-CR19" publication-type="journal">Shaker, S. A. et al. Propolis-loaded nanostructured lipid carriers halt breast cancer progression through miRNA-223 related pathways: an in-vitro/in-vivo experiment. <italic>Sci. Rep.</italic><bold>13</bold> (1), 15752. 10.1038/s41598-023-42709-7 (2023).<pub-id pub-id-type="pmid">37735586</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Saddiq</surname><given-names>AA</given-names></name><name><surname>Danial</surname><given-names>EN</given-names></name></person-group><article-title>Effect of Propolis as a food additive on the growth rate of the beneficial bacteria</article-title><source>Main Group Chem.</source><year>2014</year><volume>13</volume><issue>3</issue><fpage>223</fpage><lpage>332</lpage><pub-id pub-id-type="doi">10.3233/MGC-140135</pub-id></element-citation><mixed-citation id="mc-CR20" publication-type="journal">Saddiq, A. A. &#x00026; Danial, E. N. Effect of Propolis as a food additive on the growth rate of the beneficial bacteria. <italic>Main Group Chem.</italic><bold>13</bold> (3), 223&#x02013;332. 10.3233/MGC-140135 (2014).</mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><mixed-citation publication-type="other">Santos-Buelga, C. &#x00026; Gonz&#x000e1;lez-Param&#x000e1;s, A. M. Bee products-chemical and biological properties. <italic>Chemical Composition of Honey. Springer</italic> 43&#x02013;82 <ext-link ext-link-type="uri" xlink:href="https://link.springer.com/book/10.1007/978-3-319-59689-1">https://link.springer.com/book/10.1007/978-3-319-59689-1</ext-link> (2017).</mixed-citation></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Ani</surname><given-names>I</given-names></name><name><surname>Zimmermann</surname><given-names>S</given-names></name><name><surname>Reichling</surname><given-names>J</given-names></name><name><surname>Wink</surname><given-names>M</given-names></name></person-group><article-title>Antimicrobial activities of European propolis collected from various geographic origins alone and in combination with antibiotics</article-title><source>Medicines</source><year>2018</year><volume>5</volume><issue>1</issue><fpage>2</fpage><pub-id pub-id-type="doi">10.3390/medicines5010002</pub-id><pub-id pub-id-type="pmid">29301368</pub-id>
</element-citation><mixed-citation id="mc-CR22" publication-type="journal">Al-Ani, I., Zimmermann, S., Reichling, J. &#x00026; Wink, M. Antimicrobial activities of European propolis collected from various geographic origins alone and in combination with antibiotics. <italic>Medicines</italic><bold>5</bold> (1), 2. 10.3390/medicines5010002 (2018).<pub-id pub-id-type="pmid">29301368</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>El Menyiy</surname><given-names>N</given-names></name><name><surname>Bakour</surname><given-names>M</given-names></name><name><surname>El Ghouizi</surname><given-names>A</given-names></name><name><surname>El Guendouz</surname><given-names>S</given-names></name><name><surname>Lyoussi</surname><given-names>B</given-names></name></person-group><article-title>Influence of geographic origin and plant source on physicochemical properties, mineral content, and antioxidant and antibacterial activities of Moroccan Propolis</article-title><source>Int. J. Food Sci.</source><year>2021</year><volume>2021</volume><issue>1</issue><fpage>5570224</fpage><pub-id pub-id-type="doi">10.1155/2021/5570224</pub-id><pub-id pub-id-type="pmid">33791359</pub-id>
</element-citation><mixed-citation id="mc-CR23" publication-type="journal">El Menyiy, N., Bakour, M., El Ghouizi, A., El Guendouz, S. &#x00026; Lyoussi, B. Influence of geographic origin and plant source on physicochemical properties, mineral content, and antioxidant and antibacterial activities of Moroccan Propolis. <italic>Int. J. Food Sci.</italic><bold>2021</bold> (1), 5570224. 10.1155/2021/5570224 (2021).<pub-id pub-id-type="pmid">33791359</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Salatino</surname><given-names>A</given-names></name></person-group><article-title>Perspectives for uses of propolis in therapy against infectious diseases</article-title><source>Molecules</source><year>2022</year><volume>27</volume><issue>14</issue><fpage>4594</fpage><pub-id pub-id-type="doi">10.3390/molecules27144594</pub-id><pub-id pub-id-type="pmid">35889466</pub-id>
</element-citation><mixed-citation id="mc-CR24" publication-type="journal">Salatino, A. Perspectives for uses of propolis in therapy against infectious diseases. <italic>Molecules</italic><bold>27</bold> (14), 4594. 10.3390/molecules27144594 (2022).<pub-id pub-id-type="pmid">35889466</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><mixed-citation publication-type="other">Pincus, D. H. Microbial identification using the bioM&#x000e9;rieux Vitek<sup>&#x000ae;</sup> 2 system. Encyclopedia of Rapid Microbiological Methods. Bethesda, MD: <italic>Parenteral Drug Association.</italic> 1&#x02013;32 <ext-link ext-link-type="uri" xlink:href="https://store.pda.org/tableofcontents/ermm_v2_ch01.pdf">https://store.pda.org/tableofcontents/ermm_v2_ch01.pdf</ext-link> (2006).</mixed-citation></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>Barry</surname><given-names>A</given-names></name><etal/></person-group><article-title>Quality control limits for fluconazole disk susceptibility tests on Mueller-Hinton agar with glucose and methylene blue</article-title><source>J. Clin. Microbiol.</source><year>2003</year><volume>41</volume><issue>7</issue><fpage>3410</fpage><lpage>3412</lpage><pub-id pub-id-type="doi">10.1128/jcm.41.7.3410-3412.2003</pub-id><pub-id pub-id-type="pmid">12843106</pub-id>
</element-citation><mixed-citation id="mc-CR26" publication-type="journal">Barry, A. et al. Quality control limits for fluconazole disk susceptibility tests on Mueller-Hinton agar with glucose and methylene blue. <italic>J. Clin. Microbiol.</italic><bold>41</bold> (7), 3410&#x02013;3412. 10.1128/jcm.41.7.3410-3412.2003 (2003).<pub-id pub-id-type="pmid">12843106</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><mixed-citation publication-type="other">National Committee for Clinical Laboratory Standards (NCCLS). <italic>Methods for Dilution Antimicrobial Susceptibility Tests of bacteria that Grow Aerobically: Approved Standard M100-S12</italic> (NCCLS, 2002).</mixed-citation></ref><ref id="CR28"><label>28.</label><mixed-citation publication-type="other">Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 30th ed. CLSI supplement M100. Wayne, PA: CLSI. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.nih.org.pk/wp-content/uploads/2021/02/CLSI-2020.pdf">https://www.nih.org.pk/wp-content/uploads/2021/02/CLSI-2020.pdf</ext-link> (2020).</mixed-citation></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>Noori</surname><given-names>AL</given-names></name><name><surname>Al-Ghamdi</surname><given-names>A</given-names></name><name><surname>Ansari</surname><given-names>MJ</given-names></name><name><surname>Al-Attal</surname><given-names>Y</given-names></name><name><surname>Salom</surname><given-names>K</given-names></name></person-group><article-title>Synergistic effects of honey and propolis toward drug multi-resistant Staphylococcus aureus, Escherichia coli and Candida albicans isolates in single and polymicrobial cultures</article-title><source>Int. J. Med. Sci.</source><year>2012</year><volume>9</volume><issue>9</issue><fpage>793</fpage><pub-id pub-id-type="doi">10.7150/ijms.4722</pub-id><pub-id pub-id-type="pmid">23136543</pub-id>
</element-citation><mixed-citation id="mc-CR29" publication-type="journal">Noori, A. L., Al-Ghamdi, A., Ansari, M. J., Al-Attal, Y. &#x00026; Salom, K. Synergistic effects of honey and propolis toward drug multi-resistant Staphylococcus aureus, Escherichia coli and Candida albicans isolates in single and polymicrobial cultures. <italic>Int. J. Med. Sci.</italic><bold>9</bold> (9), 793. 10.7150/ijms.4722 (2012).<pub-id pub-id-type="pmid">23136543</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name><surname>Afsar</surname><given-names>T</given-names></name><etal/></person-group><article-title>Bioassay-guided isolation and characterization of lead antimicrobial compounds from Acacia Hydaspica plant extract</article-title><source>AMB Express</source><year>2022</year><volume>12</volume><issue>1</issue><fpage>156</fpage><pub-id pub-id-type="doi">10.1186/s13568-022-01501-y</pub-id><pub-id pub-id-type="pmid">36520322</pub-id>
</element-citation><mixed-citation id="mc-CR30" publication-type="journal">Afsar, T. et al. Bioassay-guided isolation and characterization of lead antimicrobial compounds from Acacia Hydaspica plant extract. <italic>AMB Express</italic>. <bold>12</bold> (1), 156. 10.1186/s13568-022-01501-y (2022).<pub-id pub-id-type="pmid">36520322</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name><surname>Villas-B&#x000f4;as</surname><given-names>SG</given-names></name><name><surname>Noel</surname><given-names>S</given-names></name><name><surname>Lane</surname><given-names>GA</given-names></name><name><surname>Attwood</surname><given-names>G</given-names></name><name><surname>Cookson</surname><given-names>A</given-names></name></person-group><article-title>Extracellular metabolomics: a metabolic footprinting approach to assess fiber degradation in complex media</article-title><source>Anal. Biochem.</source><year>2006</year><volume>349</volume><issue>2</issue><fpage>297</fpage><lpage>305</lpage><pub-id pub-id-type="doi">10.1016/j.ab.2005.11.019</pub-id><pub-id pub-id-type="pmid">16356465</pub-id>
</element-citation><mixed-citation id="mc-CR31" publication-type="journal">Villas-B&#x000f4;as, S. G., Noel, S., Lane, G. A., Attwood, G. &#x00026; Cookson, A. Extracellular metabolomics: a metabolic footprinting approach to assess fiber degradation in complex media. <italic>Anal. Biochem.</italic><bold>349</bold> (2), 297&#x02013;305. 10.1016/j.ab.2005.11.019 (2006).<pub-id pub-id-type="pmid">16356465</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name><surname>Abdel-Aziz</surname><given-names>AW</given-names></name><name><surname>Elwan</surname><given-names>NM</given-names></name><name><surname>Shaaban</surname><given-names>RS</given-names></name><name><surname>Osman</surname><given-names>NS</given-names></name><name><surname>Mohamed</surname><given-names>MA</given-names></name></person-group><article-title>HighPerformance liquid chromatographyfingerprint analyses, in vitro cytotoxicity, antimicrobial and antioxidant activities of the extracts of Ceiba speciosa growing in Egypt</article-title><source>Egypt. J. Chem.</source><year>2021</year><volume>64</volume><issue>4</issue><fpage>1831</fpage><lpage>1843</lpage><pub-id pub-id-type="doi">10.21608/ejchem.2021.58716.3267</pub-id></element-citation><mixed-citation id="mc-CR32" publication-type="journal">Abdel-Aziz, A. W., Elwan, N. M., Shaaban, R. S., Osman, N. S. &#x00026; Mohamed, M. A. HighPerformance liquid chromatographyfingerprint analyses, in vitro cytotoxicity, antimicrobial and antioxidant activities of the extracts of Ceiba speciosa growing in Egypt. <italic>Egypt. J. Chem.</italic><bold>64</bold> (4), 1831&#x02013;1843. 10.21608/ejchem.2021.58716.3267 (2021).</mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name><surname>Kuropatnicki</surname><given-names>AK</given-names></name><name><surname>Szliszka</surname><given-names>E</given-names></name><name><surname>Krol</surname><given-names>W</given-names></name></person-group><article-title>Historical aspects of propolis research in modern times</article-title><source>Evidence-Based Complement. Altern. Med.</source><year>2013</year><volume>2013</volume><issue>1</issue><fpage>964149</fpage><pub-id pub-id-type="doi">10.1155/2013/964149</pub-id></element-citation><mixed-citation id="mc-CR33" publication-type="journal">Kuropatnicki, A. K., Szliszka, E. &#x00026; Krol, W. Historical aspects of propolis research in modern times. <italic>Evidence-Based Complement. Altern. Med.</italic><bold>2013</bold> (1), 964149. 10.1155/2013/964149 (2013).</mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name><surname>Alegun</surname><given-names>O</given-names></name><name><surname>Pandeya</surname><given-names>A</given-names></name><name><surname>Cui</surname><given-names>J</given-names></name><name><surname>Ojo</surname><given-names>I</given-names></name><name><surname>Wei</surname><given-names>Y</given-names></name></person-group><article-title>Donnan potential across the outer membrane of gram-negative bacteria and its effect on the permeability of antibiotics</article-title><source>Antibiotics</source><year>2021</year><volume>10</volume><issue>6</issue><fpage>701</fpage><pub-id pub-id-type="doi">10.3390/antibiotics10060701</pub-id><pub-id pub-id-type="pmid">34208097</pub-id>
</element-citation><mixed-citation id="mc-CR34" publication-type="journal">Alegun, O., Pandeya, A., Cui, J., Ojo, I. &#x00026; Wei, Y. Donnan potential across the outer membrane of gram-negative bacteria and its effect on the permeability of antibiotics. <italic>Antibiotics</italic><bold>10</bold> (6), 701. 10.3390/antibiotics10060701 (2021).<pub-id pub-id-type="pmid">34208097</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name><surname>Kujumgiev</surname><given-names>A</given-names></name><etal/></person-group><article-title>Antibacterial, antifungal and antiviral activity of propolis of different geographic origin</article-title><source>J. Ethnopharmacol.</source><year>1999</year><volume>64</volume><issue>3</issue><fpage>235</fpage><lpage>240</lpage><pub-id pub-id-type="doi">10.1016/s0378-8741(98)00131-7</pub-id><pub-id pub-id-type="pmid">10363838</pub-id>
</element-citation><mixed-citation id="mc-CR35" publication-type="journal">Kujumgiev, A. et al. Antibacterial, antifungal and antiviral activity of propolis of different geographic origin. <italic>J. Ethnopharmacol.</italic><bold>64</bold> (3), 235&#x02013;240. 10.1016/s0378-8741(98)00131-7 (1999).<pub-id pub-id-type="pmid">10363838</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez</surname><given-names>BE</given-names></name><etal/></person-group><article-title>Severe Staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus</article-title><source>Pediatrics</source><year>2005</year><volume>115</volume><issue>3</issue><fpage>642</fpage><lpage>648</lpage><pub-id pub-id-type="doi">10.1542/peds.2004-2300</pub-id><pub-id pub-id-type="pmid">15741366</pub-id>
</element-citation><mixed-citation id="mc-CR36" publication-type="journal">Gonzalez, B. E. et al. Severe Staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus. <italic>Pediatrics</italic><bold>115</bold> (3), 642&#x02013;648. 10.1542/peds.2004-2300 (2005).<pub-id pub-id-type="pmid">15741366</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><mixed-citation publication-type="other">Taher, N. M. Synergistic effect of Propolis extract and antibiotics on Multi-Resist Klebsiella Pneumoniae strain isolated Fom wound. <italic>Adv. Life Sci. Technol.</italic><bold>43</bold>. <ext-link ext-link-type="uri" xlink:href="https://core.ac.uk/reader/234687340">https://core.ac.uk/reader/234687340</ext-link> (2016).</mixed-citation></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name><surname>Johnston</surname><given-names>M</given-names></name><name><surname>McBride</surname><given-names>M</given-names></name><name><surname>Dahiya</surname><given-names>D</given-names></name><name><surname>Owusu-Apenten</surname><given-names>R</given-names></name><name><surname>Nigam</surname><given-names>PS</given-names></name></person-group><article-title>Antibacterial activity of Manuka honey and its components: an overview</article-title><source>AIMS Microbiol.</source><year>2018</year><volume>4</volume><issue>4</issue><fpage>655</fpage><pub-id pub-id-type="doi">10.3934/microbiol.2018.4.655</pub-id><pub-id pub-id-type="pmid">31294240</pub-id>
</element-citation><mixed-citation id="mc-CR38" publication-type="journal">Johnston, M., McBride, M., Dahiya, D., Owusu-Apenten, R. &#x00026; Nigam, P. S. Antibacterial activity of Manuka honey and its components: an overview. <italic>AIMS Microbiol.</italic><bold>4</bold> (4), 655. 10.3934/microbiol.2018.4.655 (2018).<pub-id pub-id-type="pmid">31294240</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name><surname>Prudence</surname><given-names>IA</given-names></name><name><surname>Celestin</surname><given-names>MP</given-names></name><name><surname>Hiberte</surname><given-names>M</given-names></name><name><surname>Josue</surname><given-names>I</given-names></name><name><surname>Eric</surname><given-names>S</given-names></name></person-group><article-title>The effect of honey on Bacteria isolated from urinary tract infections among patients attending ruhengeri referral hospital</article-title><source>J. Drug Delivery Ther.</source><year>2024</year><volume>14</volume><issue>4</issue><fpage>10</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.22270/jddt.v14i4.6104</pub-id></element-citation><mixed-citation id="mc-CR39" publication-type="journal">Prudence, I. A., Celestin, M. P., Hiberte, M., Josue, I. &#x00026; Eric, S. The effect of honey on Bacteria isolated from urinary tract infections among patients attending ruhengeri referral hospital. <italic>J. Drug Delivery Ther.</italic><bold>14</bold> (4), 10&#x02013;13. 10.22270/jddt.v14i4.6104 (2024).</mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name><surname>Vic&#x00103;</surname><given-names>ML</given-names></name><etal/></person-group><article-title>Antibacterial activity of propolis extracts from the central region of Romania against neisseria gonorrhoeae</article-title><source>Antibiotics</source><year>2021</year><volume>10</volume><issue>6</issue><fpage>689</fpage><pub-id pub-id-type="doi">10.3390/antibiotics10060689</pub-id><pub-id pub-id-type="pmid">34201299</pub-id>
</element-citation><mixed-citation id="mc-CR40" publication-type="journal">Vic&#x00103;, M. L. et al. Antibacterial activity of propolis extracts from the central region of Romania against neisseria gonorrhoeae. <italic>Antibiotics</italic><bold>10</bold> (6), 689. 10.3390/antibiotics10060689 (2021).<pub-id pub-id-type="pmid">34201299</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name><surname>Hamouda</surname><given-names>SM</given-names></name><name><surname>Abd El Rahman</surname><given-names>MF</given-names></name><name><surname>Abdul-Hafeez</surname><given-names>MM</given-names></name><name><surname>Gerges</surname><given-names>AE</given-names></name></person-group><article-title>Egyptian fennel honey and/or propolis against MRSA harboring both MecA &#x00026; IcaA genes</article-title><source>Int. J. Complement. Altern. Med.</source><year>2018</year><volume>11</volume><fpage>180</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.15406/ijcam.2018.11.00392</pub-id></element-citation><mixed-citation id="mc-CR41" publication-type="journal">Hamouda, S. M., Abd El Rahman, M. F., Abdul-Hafeez, M. M. &#x00026; Gerges, A. E. Egyptian fennel honey and/or propolis against MRSA harboring both MecA &#x00026; IcaA genes. <italic>Int. J. Complement. Altern. Med.</italic><bold>11</bold>, 180&#x02013;185. 10.15406/ijcam.2018.11.00392 (2018).</mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name><surname>Bouaroura</surname><given-names>A</given-names></name><etal/></person-group><article-title>Phytochemical investigation of phenolic constituents and in vitro evaluation of antioxidant activity of five Algerian Propolis</article-title><source>Curr. Bioact. Compd.</source><year>2021</year><volume>17</volume><issue>8</issue><fpage>79</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.2174/1573407216999201231200041</pub-id></element-citation><mixed-citation id="mc-CR42" publication-type="journal">Bouaroura, A. et al. Phytochemical investigation of phenolic constituents and in vitro evaluation of antioxidant activity of five Algerian Propolis. <italic>Curr. Bioact. Compd.</italic><bold>17</bold> (8), 79&#x02013;87. 10.2174/1573407216999201231200041 (2021).</mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>He</surname><given-names>X</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name></person-group><article-title>Phytochemical composition, antioxidant activity, &#x003b1;-glucosidase and acetylcholinesterase inhibitory activity of Quinoa extract and its fractions</article-title><source>Molecules</source><year>2022</year><volume>27</volume><issue>8</issue><fpage>2420</fpage><pub-id pub-id-type="doi">10.3390/molecules27082420</pub-id><pub-id pub-id-type="pmid">35458616</pub-id>
</element-citation><mixed-citation id="mc-CR43" publication-type="journal">Chen, X., He, X., Sun, J. &#x00026; Wang, Z. Phytochemical composition, antioxidant activity, &#x003b1;-glucosidase and acetylcholinesterase inhibitory activity of Quinoa extract and its fractions. <italic>Molecules</italic><bold>27</bold> (8), 2420. 10.3390/molecules27082420 (2022).<pub-id pub-id-type="pmid">35458616</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name><surname>Elnakady</surname><given-names>YA</given-names></name><etal/></person-group><article-title>Characteristics, chemical compositions and biological activities of propolis from Al-Bahah, Saudi Arabia</article-title><source>Sci. Rep.</source><year>2017</year><volume>7</volume><issue>1</issue><fpage>41453</fpage><pub-id pub-id-type="doi">10.1038/srep41453</pub-id><pub-id pub-id-type="pmid">28165013</pub-id>
</element-citation><mixed-citation id="mc-CR44" publication-type="journal">Elnakady, Y. A. et al. Characteristics, chemical compositions and biological activities of propolis from Al-Bahah, Saudi Arabia. <italic>Sci. Rep.</italic><bold>7</bold> (1), 41453. 10.1038/srep41453 (2017).<pub-id pub-id-type="pmid">28165013</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name><surname>Mouhoubi-Tafinine</surname><given-names>Z</given-names></name><name><surname>Ouchemoukh</surname><given-names>S</given-names></name><name><surname>Tamendjari</surname><given-names>A</given-names></name></person-group><article-title>Antioxydant activity of some Algerian honey and propolis</article-title><source>Ind. Crops Prod.</source><year>2016</year><volume>88</volume><fpage>85</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1016/j.indcrop.2016.02.033</pub-id></element-citation><mixed-citation id="mc-CR45" publication-type="journal">Mouhoubi-Tafinine, Z., Ouchemoukh, S. &#x00026; Tamendjari, A. Antioxydant activity of some Algerian honey and propolis. <italic>Ind. Crops Prod.</italic><bold>88</bold>, 85&#x02013;90. 10.1016/j.indcrop.2016.02.033 (2016).</mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name><surname>Nada</surname><given-names>AA</given-names></name><etal/></person-group><article-title>Synergistic effect of potential alpha-amylase inhibitors from Egyptian propolis with acarbose using in Silico and in vitro combination analysis</article-title><source>BMC Complement. Med. Ther.</source><year>2024</year><volume>24</volume><issue>1</issue><fpage>65</fpage><pub-id pub-id-type="doi">10.1186/s12906-024-04348-x</pub-id><pub-id pub-id-type="pmid">38291462</pub-id>
</element-citation><mixed-citation id="mc-CR46" publication-type="journal">Nada, A. A. et al. Synergistic effect of potential alpha-amylase inhibitors from Egyptian propolis with acarbose using in Silico and in vitro combination analysis. <italic>BMC Complement. Med. Ther.</italic><bold>24</bold> (1), 65. 10.1186/s12906-024-04348-x (2024).<pub-id pub-id-type="pmid">38291462</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>W</given-names></name><name><surname>Lowen</surname><given-names>N</given-names></name><name><surname>Blake</surname><given-names>DJ</given-names></name></person-group><article-title>Caffeic acid esters are effective bactericidal compounds against Paenibacillus larvae by altering intracellular oxidant and antioxidant levels</article-title><source>Biomolecules</source><year>2019</year><volume>9</volume><issue>8</issue><fpage>312</fpage><pub-id pub-id-type="doi">10.3390/biom9080312</pub-id><pub-id pub-id-type="pmid">31357646</pub-id>
</element-citation><mixed-citation id="mc-CR47" publication-type="journal">Collins, W., Lowen, N. &#x00026; Blake, D. J. Caffeic acid esters are effective bactericidal compounds against Paenibacillus larvae by altering intracellular oxidant and antioxidant levels. <italic>Biomolecules</italic><bold>9</bold> (8), 312. 10.3390/biom9080312 (2019).<pub-id pub-id-type="pmid">31357646</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name><surname>Kurek-G&#x000f3;recka</surname><given-names>A</given-names></name><etal/></person-group><article-title>Comparison of the antioxidant activity of propolis samples from different geographical regions</article-title><source>Plants</source><year>2022</year><volume>11</volume><issue>9</issue><fpage>1203</fpage><pub-id pub-id-type="doi">10.3390/plants11091203</pub-id><pub-id pub-id-type="pmid">35567206</pub-id>
</element-citation><mixed-citation id="mc-CR48" publication-type="journal">Kurek-G&#x000f3;recka, A. et al. Comparison of the antioxidant activity of propolis samples from different geographical regions. <italic>Plants</italic><bold>11</bold> (9), 1203. 10.3390/plants11091203 (2022).<pub-id pub-id-type="pmid">35567206</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR49"><label>49.</label><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>H</given-names></name><etal/></person-group><article-title>Isolation and characterization of five glycerol esters from Wuhan propolis and their potential anti-inflammatory properties</article-title><source>J. Agric. Food Chem.</source><year>2012</year><volume>60</volume><issue>40</issue><fpage>10041</fpage><lpage>10047</lpage><pub-id pub-id-type="doi">10.1021/jf302601m</pub-id><pub-id pub-id-type="pmid">22978445</pub-id>
</element-citation><mixed-citation id="mc-CR49" publication-type="journal">Shi, H. et al. Isolation and characterization of five glycerol esters from Wuhan propolis and their potential anti-inflammatory properties. <italic>J. Agric. Food Chem.</italic><bold>60</bold> (40), 10041&#x02013;10047. 10.1021/jf302601m (2012).<pub-id pub-id-type="pmid">22978445</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR50"><label>50.</label><citation-alternatives><element-citation id="ec-CR50" publication-type="journal"><person-group person-group-type="author"><name><surname>Guzman</surname><given-names>JD</given-names></name></person-group><article-title>Natural cinnamic acids, synthetic derivatives and hybrids with antimicrobial activity</article-title><source>Molecules</source><year>2014</year><volume>19</volume><issue>12</issue><fpage>19292</fpage><lpage>19349</lpage><pub-id pub-id-type="doi">10.3390/molecules191219292</pub-id><pub-id pub-id-type="pmid">25429559</pub-id>
</element-citation><mixed-citation id="mc-CR50" publication-type="journal">Guzman, J. D. Natural cinnamic acids, synthetic derivatives and hybrids with antimicrobial activity. <italic>Molecules</italic><bold>19</bold> (12), 19292&#x02013;19349. 10.3390/molecules191219292 (2014).<pub-id pub-id-type="pmid">25429559</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR51"><label>51.</label><citation-alternatives><element-citation id="ec-CR51" publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>CP</given-names></name><name><surname>Wang</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>GQ</given-names></name><name><surname>Hu</surname><given-names>FL</given-names></name></person-group><article-title>Recent advances in the chemical composition of propolis</article-title><source>Molecules</source><year>2014</year><volume>19</volume><issue>12</issue><fpage>19610</fpage><lpage>19632</lpage><pub-id pub-id-type="doi">10.3390/molecules191219610</pub-id><pub-id pub-id-type="pmid">25432012</pub-id>
</element-citation><mixed-citation id="mc-CR51" publication-type="journal">Huang, S., Zhang, C. P., Wang, K., Li, G. Q. &#x00026; Hu, F. L. Recent advances in the chemical composition of propolis. <italic>Molecules</italic><bold>19</bold> (12), 19610&#x02013;19632. 10.3390/molecules191219610 (2014).<pub-id pub-id-type="pmid">25432012</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR52"><label>52.</label><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name><surname>Machado</surname><given-names>CS</given-names></name><name><surname>Finger</surname><given-names>D</given-names></name><name><surname>Caetano</surname><given-names>IK</given-names></name><name><surname>Torres</surname><given-names>YR</given-names></name></person-group><article-title>Multivariate GC-MS data analysis of the apolar fraction of brown propolis produced in Southern Brazil</article-title><source>J. Apic. Res.</source><year>2023</year><volume>14</volume><fpage>1</fpage><lpage>2</lpage><pub-id pub-id-type="doi">10.1080/00218839.2023.2212487</pub-id></element-citation><mixed-citation id="mc-CR52" publication-type="journal">Machado, C. S., Finger, D., Caetano, I. K. &#x00026; Torres, Y. R. Multivariate GC-MS data analysis of the apolar fraction of brown propolis produced in Southern Brazil. <italic>J. Apic. Res.</italic><bold>14</bold>, 1&#x02013;2. 10.1080/00218839.2023.2212487 (2023).</mixed-citation></citation-alternatives></ref><ref id="CR53"><label>53.</label><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name><surname>Vandeputte</surname><given-names>OM</given-names></name><etal/></person-group><article-title>The Flavanone naringenin reduces the production of quorum sensing-controlled virulence factors in Pseudomonas aeruginosa PAO1</article-title><source>Microbiology</source><year>2011</year><volume>157</volume><issue>7</issue><fpage>2120</fpage><lpage>2132</lpage><pub-id pub-id-type="doi">10.1099/mic.0.049338-0</pub-id><pub-id pub-id-type="pmid">21546585</pub-id>
</element-citation><mixed-citation id="mc-CR53" publication-type="journal">Vandeputte, O. M. et al. The Flavanone naringenin reduces the production of quorum sensing-controlled virulence factors in Pseudomonas aeruginosa PAO1. <italic>Microbiology</italic><bold>157</bold> (7), 2120&#x02013;2132. 10.1099/mic.0.049338-0 (2011).<pub-id pub-id-type="pmid">21546585</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR54"><label>54.</label><mixed-citation publication-type="other">Shariati, A. et al. Inhibitory effect of natural compounds on quorum sensing system in Pseudomonas aeruginosa: a helpful promise for managing biofilm community. <italic>Front. Pharmacology.</italic><bold>15</bold>, 1350391 10.3389/fphar.2024.1350391 (2024).</mixed-citation></ref><ref id="CR55"><label>55.</label><mixed-citation publication-type="other">do Nascimento, T. G. et al. Comprehensive multivariate correlations between climatic effect, metabolite-profile, antioxidant capacity and antibacterial activity of Brazilian red propolis metabolites during seasonal study. <italic>Sci. Rep.</italic><bold>9</bold> (1), 18293 10.1038/s41598-019-54591-3 (2019).</mixed-citation></ref><ref id="CR56"><label>56.</label><mixed-citation publication-type="other">Dantas, D. M. et al. Naringenin as potentiator of Norfloxacin efficacy through Inhibition of the NorA efflux pump in Staphylococcus aureus. <italic>Microb. Pathog.</italic><bold>107504</bold>10.1016/j.micpath.2025.107504 (2025).</mixed-citation></ref><ref id="CR57"><label>57.</label><citation-alternatives><element-citation id="ec-CR57" publication-type="journal"><person-group person-group-type="author"><name><surname>Vasconcelos</surname><given-names>NG</given-names></name><name><surname>Croda</surname><given-names>J</given-names></name><name><surname>Simionatto</surname><given-names>S</given-names></name></person-group><article-title>Antibacterial mechanisms of cinnamon and its constituents: A review</article-title><source>Microb. Pathog.</source><year>2018</year><volume>120</volume><fpage>198</fpage><lpage>203</lpage><pub-id pub-id-type="doi">10.1016/j.micpath.2018.04.036</pub-id><pub-id pub-id-type="pmid">29702210</pub-id>
</element-citation><mixed-citation id="mc-CR57" publication-type="journal">Vasconcelos, N. G., Croda, J. &#x00026; Simionatto, S. Antibacterial mechanisms of cinnamon and its constituents: A review. <italic>Microb. Pathog.</italic><bold>120</bold>, 198&#x02013;203. 10.1016/j.micpath.2018.04.036 (2018).<pub-id pub-id-type="pmid">29702210</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR58"><label>58.</label><citation-alternatives><element-citation id="ec-CR58" publication-type="journal"><person-group person-group-type="author"><name><surname>Borges</surname><given-names>A</given-names></name><name><surname>Saavedra</surname><given-names>MJ</given-names></name><name><surname>Sim&#x000f5;es</surname><given-names>M</given-names></name></person-group><article-title>The activity of ferulic and Gallic acids in biofilm prevention and control of pathogenic bacteria</article-title><source>Biofouling</source><year>2012</year><volume>28</volume><issue>7</issue><fpage>755</fpage><lpage>767</lpage><pub-id pub-id-type="doi">10.1080/08927014.2012.706751</pub-id><pub-id pub-id-type="pmid">22823343</pub-id>
</element-citation><mixed-citation id="mc-CR58" publication-type="journal">Borges, A., Saavedra, M. J. &#x00026; Sim&#x000f5;es, M. The activity of ferulic and Gallic acids in biofilm prevention and control of pathogenic bacteria. <italic>Biofouling</italic><bold>28</bold> (7), 755&#x02013;767. 10.1080/08927014.2012.706751 (2012).<pub-id pub-id-type="pmid">22823343</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR59"><label>59.</label><citation-alternatives><element-citation id="ec-CR59" publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>P</given-names></name><name><surname>Song</surname><given-names>B</given-names></name><name><surname>Neto</surname><given-names>C</given-names></name><name><surname>Camesano</surname><given-names>TA</given-names></name></person-group><article-title>Atomic force microscopy-guided fractionation reveals the influence of cranberry phytochemicals on adhesion of Escherichia coli</article-title><source>Food Funct.</source><year>2016</year><volume>7</volume><issue>6</issue><fpage>2655</fpage><lpage>2666</lpage><pub-id pub-id-type="doi">10.1039/C6FO00109B</pub-id><pub-id pub-id-type="pmid">27220364</pub-id>
</element-citation><mixed-citation id="mc-CR59" publication-type="journal">Gupta, P., Song, B., Neto, C. &#x00026; Camesano, T. A. Atomic force microscopy-guided fractionation reveals the influence of cranberry phytochemicals on adhesion of Escherichia coli. <italic>Food Funct.</italic><bold>7</bold> (6), 2655&#x02013;2666. 10.1039/C6FO00109B (2016).<pub-id pub-id-type="pmid">27220364</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR60"><label>60.</label><citation-alternatives><element-citation id="ec-CR60" publication-type="journal"><person-group person-group-type="author"><name><surname>Bernal-Mercado</surname><given-names>AT</given-names></name><etal/></person-group><article-title>Comparison of single and combined use of Catechin, Protocatechuic, and vanillic acids as antioxidant and antibacterial agents against uropathogenic Escherichia coli at planktonic and biofilm levels</article-title><source>Molecules</source><year>2018</year><volume>23</volume><issue>11</issue><fpage>2813</fpage><pub-id pub-id-type="doi">10.3390/molecules23112813</pub-id><pub-id pub-id-type="pmid">30380712</pub-id>
</element-citation><mixed-citation id="mc-CR60" publication-type="journal">Bernal-Mercado, A. T. et al. Comparison of single and combined use of Catechin, Protocatechuic, and vanillic acids as antioxidant and antibacterial agents against uropathogenic Escherichia coli at planktonic and biofilm levels. <italic>Molecules</italic><bold>23</bold> (11), 2813. 10.3390/molecules23112813 (2018).<pub-id pub-id-type="pmid">30380712</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR61"><label>61.</label><citation-alternatives><element-citation id="ec-CR61" publication-type="journal"><person-group person-group-type="author"><name><surname>Pamplona-Zomenhan</surname><given-names>LC</given-names></name><name><surname>Pamplona</surname><given-names>BC</given-names></name><name><surname>Silva</surname><given-names>CB</given-names></name><name><surname>Marcucci</surname><given-names>MC</given-names></name><name><surname>Mimica</surname><given-names>LM</given-names></name></person-group><article-title>Evaluation of the in vitro antimicrobial activity of an ethanol extract of Brazilian classified propolis on strains of Staphylococcus aureus</article-title><source>Brazilian J. Microbiol.</source><year>2011</year><volume>42</volume><fpage>1259</fpage><lpage>1264</lpage><pub-id pub-id-type="doi">10.1590/S1517-83822011000400002</pub-id></element-citation><mixed-citation id="mc-CR61" publication-type="journal">Pamplona-Zomenhan, L. C., Pamplona, B. C., Silva, C. B., Marcucci, M. C. &#x00026; Mimica, L. M. Evaluation of the in vitro antimicrobial activity of an ethanol extract of Brazilian classified propolis on strains of Staphylococcus aureus. <italic>Brazilian J. Microbiol.</italic><bold>42</bold>, 1259&#x02013;1264. 10.1590/S1517-83822011000400002 (2011).</mixed-citation></citation-alternatives></ref><ref id="CR62"><label>62.</label><citation-alternatives><element-citation id="ec-CR62" publication-type="journal"><person-group person-group-type="author"><name><surname>De Rossi</surname><given-names>L</given-names></name><name><surname>Rocchetti</surname><given-names>G</given-names></name><name><surname>Lucini</surname><given-names>L</given-names></name><name><surname>Rebecchi</surname><given-names>A</given-names></name></person-group><article-title>Antimicrobial potential of polyphenols: mechanisms of action and microbial responses-a narrative review</article-title><source>Antioxidants</source><year>2011</year><volume>14</volume><issue>2</issue><fpage>200</fpage><pub-id pub-id-type="doi">10.3390/antiox14020200</pub-id></element-citation><mixed-citation id="mc-CR62" publication-type="journal">De Rossi, L., Rocchetti, G., Lucini, L., &#x00026; Rebecchi, A. Antimicrobial potential of polyphenols: mechanisms of action and microbial responses-a narrative review. <italic>Antioxidants</italic><bold>14</bold> (2), 200 10.3390/antiox14020200 (2025).</mixed-citation></citation-alternatives></ref></ref-list></back></article>